MST1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T298 | Sugiyama | SHTN1 KIAA1598 | EERIQHQQKVKELEEQLENEtLHKEIHNLKQQLELLEEDKK |
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00151 | T78 | Sugiyama | PDLIM1 CLIM1 CLP36 | TSNMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGK |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O14744 | T80 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O14979 | T178 | Sugiyama | HNRNPDL HNRPDL JKTBP | DTsKKDLtEyLSRFGEVVDCtIKTDPVTGRSRGFGFVLFKD |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15212 | T75 | Sugiyama | PFDN6 HKE2 PFD6 | VVFKLLGPVLVKQELGEARAtVGKRLDyItAEIKRYESQLR |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | T142 | Sugiyama | HNRNPR HNRPR | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQPG |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43524 | S209 | GPS6|SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | RCVPYFKDKGDSNSSAGWKNsIRHNLsLHSRFMRVQNEGTG |
| O43524 | S215 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | KDKGDSNSSAGWKNsIRHNLsLHSRFMRVQNEGTGKssWWI |
| O43524 | S231 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | RHNLsLHSRFMRVQNEGTGKssWWIINPDGGKsGKAPRRRA |
| O43524 | S232 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | HNLsLHSRFMRVQNEGTGKssWWIINPDGGKsGKAPRRRAV |
| O43524 | S243 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | VQNEGTGKssWWIINPDGGKsGKAPRRRAVsMDNsNKYTKS |
| O43615 | T128 | Sugiyama | TIMM44 MIMT44 TIM44 | ESETVRTSEVLRKKLGELTGtVKESLHEVSKSDLGRKIKEG |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | S511 | Sugiyama | ACTN4 | VNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQLHL |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T903 | Sugiyama | ACTN4 | MAPyQGPDAVPGALDyKsFStALyGEsDL____________ |
| O43815 | T265 | Sugiyama | STRN | sDEDEDDDVDGREKsVIDtstIVRKKALPDSGEDRDTKEAL |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | T139 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQPs |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60566 | T315 | Sugiyama | BUB1B BUBR1 MAD3L SSK1 | WIAPPMPRAKENELQAGPWNtGRsLEHRPRGNTASLIAVPA |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | T869 | Sugiyama | CTNND1 KIAA0384 | FQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDREEIQ |
| O60814 | S15 | GPS6|EPSD | H2BC12 H2BFT HIRIP1 HIST1H2BK | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75533 | T203 | Sugiyama | SF3B1 SAP155 | VVNGAAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEt |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| O95433 | T20 | Sugiyama | AHSA1 C14orf3 HSPC322 | _MAKWGEGDPRWIVEERADAtNVNNWHWtERDASNWSTDKL |
| O95433 | T28 | Sugiyama | AHSA1 C14orf3 HSPC322 | DPRWIVEERADAtNVNNWHWtERDASNWSTDKLKTLFLAVQ |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95721 | T137 | Sugiyama | SNAP29 | GGLVNYFKSKPVEtPPEQNGtLtSQPNNRLKEAISTSKEQE |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95835 | S909 | SIGNOR | LATS1 WARTS | DRLKPLERRAARQHQRCLAHsLVGTPNYIAPEVLLRTGYTQ |
| O95835 | T1079 | SIGNOR|PSP | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00519 | T735 | SIGNOR|EPSD|PSP | ABL1 ABL JTK7 | RsCsAsCVPHGAKDTEWRSVtLPRDLQStGRQFDSstFGGH |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04083 | T64 | Sugiyama | ANXA1 ANX1 LPC1 | PssDVAALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAY |
| P04083 | T70 | Sugiyama | ANXA1 ANX1 LPC1 | ALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAYLQEtGK |
| P04150 | S682 | PSP | NR3C1 GRL | EYLCMKtLLLLSSVPKDGLKsQELFDEIRMTYIKELGKAIV |
| P04150 | S746 | PSP | NR3C1 GRL | HEVVENLLNYCFQTFLDKTMsIEFPEMLAEIITNQIPKYSN |
| P04150 | T562 | PSP | NR3C1 GRL | EVLYAGYDSSVPDStWRIMTtLNMLGGRQVIAAVKWAKAIP |
| P04150 | T668 | PSP | NR3C1 GRL | YVSSELHRLQVSYEEYLCMKtLLLLSSVPKDGLKsQELFDE |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S98 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | QERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKR |
| P04406 | T104 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsAP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | T120 | Sugiyama | SSB | VTDEyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNI |
| P05455 | T123 | Sugiyama | SSB | EyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNIQMR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06748 | S43 | Sugiyama | NPM1 NPM | LKADKDyHFKVDNDENEHQLsLRTVsLGAGAKDELHIVEAE |
| P06899 | S15 | GPS6|EPSD | H2BC11 H2BFR HIST1H2BJ | ______MPEPAKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T101 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAGRE |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07711 | T332 | Sugiyama | CTSL CTSL1 | VKMAKDRRNHCGIAsAAsyPtV___________________ |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T33 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | PGFDERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEI |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T206 | Sugiyama | HSPD1 HSP60 | IsDAMKKVGRKGVITVKDGKtLNDELEIIEGMKFDRGyIsP |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11766 | T127 | Sugiyama | ADH5 ADHX FDH | KTNLCQKIRVTQGKGLMPDGtSRFTCKGKTILHYMGTSTFS |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T424 | Sugiyama | ACTN1 | sIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDL |
| P12814 | T426 | Sugiyama | ACTN1 | HEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDLAA |
| P13073 | S72 | Sugiyama | COX4I1 COX4 | VKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAE |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | T139 | Sugiyama | PDIA4 ERP70 ERP72 | KIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQEE |
| P13667 | T238 | Sugiyama | PDIA4 ERP70 ERP72 | KAAKELSKRSPPIPLAKVDAtAETDLAKRFDVsGyPTLKIF |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13984 | T16 | Sugiyama | GTF2F2 RAP30 | _____MAERGELDLTGAKQNtGVWLVKVPKYLsQQWAKASG |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P15170 | T315 | Sugiyama | GSPT1 ERF3A | NRSVDGPIRLPIVDKYKDMGtVVLGKLESGSICKGQQLVMM |
| P15311 | S536 | Sugiyama | EZR VIL2 | KRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNE |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15924 | T61 | Sugiyama | DSP | YYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDC |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16104 | S140 | EPSD | H2AX H2AFX | KtsAtVGPKAPSGGKKAtQAsQEy_________________ |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17252 | S226 | SIGNOR | PRKCA PKCA PRKACA | NESKQKTKTIRSTLNPQWNEsFtFKLKPSDKDRRLsVEIWD |
| P17252 | T228 | SIGNOR | PRKCA PKCA PRKACA | SKQKTKTIRSTLNPQWNEsFtFKLKPSDKDRRLsVEIWDWD |
| P17301 | S1180 | EPSD|PSP | ITGA2 CD49B | KRKYEKMTKNPDEIDETtELss___________________ |
| P17302 | S255 | PSP | GJA1 GJAL | GVKDRVKGKSDPyHATsGALsPAKDCGsQKyAyFNGCssPt |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | S14 | Sugiyama | RPL17 | _______MVRysLDPENPtKsCKSRGSNLRVHFKNtRETAQ |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T587 | Sugiyama | NCL | RSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETG |
| P19429 | T129 | GPS6|SIGNOR|EPSD|PSP | TNNI3 TNNC1 | EERYDIEAKVTKNITEIADLtQKIFDLRGKFKRPtLRRVRI |
| P19429 | T143 | GPS6|SIGNOR|EPSD|PSP | TNNI3 TNNC1 | TEIADLtQKIFDLRGKFKRPtLRRVRIsADAMMQALLGARA |
| P19429 | T31 | GPS6|SIGNOR|EPSD|PSP | TNNI3 TNNC1 | EPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAsRKLQLKt |
| P19429 | T51 | GPS6|SIGNOR|EPSD|PSP | TNNI3 TNNC1 | tEPHAKKKsKIsAsRKLQLKtLLLQIAKQELEREAEERRGE |
| P20290 | S126 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VNMFTNQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEM |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20290 | T140 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLGADsLt |
| P20290 | T28 | Sugiyama | BTF3 NACB OK/SW-cl.8 | AQADSRGRGRARGGCPGGEAtLsQPPPRGGTRGQEPQMKET |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P21291 | T79 | Sugiyama | CSRP1 CSRP CYRP | KSCyGKKYGPKGyGyGQGAGtLstDKGEsLGIKHEEAPGHR |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23193 | T256 | Sugiyama | TCEA1 GTF2S TFIIS | MRKNLTKEAIREHQMAKTGGtQTDLFtCGKCKKKNCTYTQV |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | T108 | Sugiyama | PPIB CYPB | YKNSKFHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENF |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23527 | S15 | GPS6|EPSD | H2BC17 H2BFH H2BFN HIST1H2BO | ______MPDPAKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T88 | Sugiyama | CFL1 CFL | yAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P25815 | T27 | Sugiyama | S100P S100E | AMGMIIDVFSRYSGSEGstQtLTKGELKVLMEKELPGFLQs |
| P26038 | T425 | Sugiyama | MSN | QAsRDQKKTQEQLALEMAELtARIsQLEMARQKKEsEAVEW |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28066 | T14 | Sugiyama | PSMA5 | _______MFLTRsEyDRGVNtFsPEGRLFQVEyAIEAIKLG |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30622 | T260 | Sugiyama | CLIP1 CYLN1 RSN | EWCGVELDEPLGKNDGAVAGtRyFQCQPKyGLFAPVHKVTK |
| P30626 | T130 | Sugiyama | SRI | IsFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYst |
| P30626 | T131 | Sugiyama | SRI | sFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYstN |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P31327 | T903 | Sugiyama | CPS1 | DILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKCLGL |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31943 | T287 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | CFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIyN |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P33778 | S15 | GPS6|SIGNOR|ELM|EPSD | H2BC3 H2BFF HIST1H2BB | ______MPEPSKSAPAPKKGsKKAITKAQKKDGKKRKRsRK |
| P33991 | T854 | Sugiyama | MCM4 CDC21 | AITKDMFEEALRALADDDFLtVtGKtVRLL___________ |
| P33991 | T859 | Sugiyama | MCM4 CDC21 | MFEEALRALADDDFLtVtGKtVRLL________________ |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35241 | T425 | Sugiyama | RDX | KQAADQMKNQEQLAAELAEFtAKIALLEEAKKKKEEEATEW |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T397 | Sugiyama | GTF2F1 RAP74 | sGGSSRGNsRPGtPsAEGGstsstLRAAASKLEQGKRVSEM |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | T1005 | Sugiyama | MYH9 | DQNCKLAKEKKLLEDRIAEFtTNLtEEEEKSKsLAKLKNKH |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35658 | T860 | Sugiyama | NUP214 CAIN CAN KIAA0023 | LEQKKKQRHLLVPERETLFNtLANNREIINQQRKRLNHLVD |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37108 | T29 | Sugiyama | SRP14 | FLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVEGF |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40925 | T225 | Sugiyama | MDH1 MDHA | KEVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMS |
| P40926 | T224 | Sugiyama | MDH2 | TIIPLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGA |
| P40926 | T227 | Sugiyama | MDH2 | PLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGAGsA |
| P40939 | T393 | Sugiyama | HADHA HADH | GAGIAQVSVDKGLKTILKDAtLtALDRGQQQVFKGLNDKVK |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P41091 | T9 | Sugiyama | EIF2S3 EIF2G | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| P41208 | T45 | Sugiyama | CETN2 CALT CEN2 | LtEEQKQEIREAFDLFDADGtGtIDVKELKVAMRALGFEPK |
| P41208 | T47 | Sugiyama | CETN2 CALT CEN2 | EEQKQEIREAFDLFDADGtGtIDVKELKVAMRALGFEPKKE |
| P42336 | T1061 | SIGNOR | PIK3CA | KQMNDAHHGGWTTKMDWIFHtIKQHALN_____________ |
| P42765 | T87 | Sugiyama | ACAA2 | IYLARHVGLRVGIPKETPALtINRLCGSGFQSIVNGCQEIC |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P43034 | T247 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | VKTFTGHREWVRMVRPNQDGtLIASCSNDQTVRVWVVATKE |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | T80 | Sugiyama | RPL27A | HYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPI |
| P46776 | T86 | Sugiyama | RPL27A | NQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRs |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T211 | Sugiyama | FASN FAS | LLKPNTSVQFLRLGMLsPEGtCKAFDtAGNGYCRSEGVVAV |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49368 | T486 | Sugiyama | CCT3 CCTG TRIC5 | LRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQTY |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49589 | T24 | Sugiyama | CARS1 CARS | SSGQQGKGRRVQPQWsPPAGtQPCRLHLyNsLtRNKEVFIP |
| P49773 | T17 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | ____MADEIAKAQVARPGGDtIFGKIIRKEIPAKIIFEDDR |
| P49792 | S1613 | Sugiyama | RANBP2 NUP358 | KAPKSGFEGMFTKKEGQWDCsVCLVRNEASATKCIACQNPG |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50990 | S162 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAKL |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51858 | T184 | Sugiyama | HDGF HMG1L2 | DsPKRPKEAENPEGEEKEAAtLEVERPLPMEVEKNstPsEP |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52948 | T172 | Sugiyama | NUP98 ADAR2 | SFTAAPTGTTIKFNPPTGTDtMVKAGVSTNISTKHQCITAM |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P54105 | T34 | Sugiyama | CLNS1A CLCI ICLN | EGLLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGF |
| P54105 | T36 | Sugiyama | CLNS1A CLCI ICLN | LLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSL |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55072 | T761 | Sugiyama | VCP HEL-220 HEL-S-70 | RFARRsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGA |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57053 | S15 | GPS6|EPSD | H2BC12L H2BFS H2BS1 | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGRKRKRSRK |
| P57721 | T174 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EIREstGAQVQVAGDMLPNstERAVTISGTPDAIIQCVKQI |
| P58876 | S15 | GPS6|EPSD | H2BC5 H2BFB HIRIP2 HIST1H2BD | ______MPEPTKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | S78 | Sugiyama | EIF4A1 DDX2A EIF4A | IQQRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDL |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61158 | T14 | Sugiyama | ACTR3 ARP3 | _______MAGRLPACVVDCGtGytKLGYAGNTEPQFIIPSC |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | T16 | Sugiyama | RPL37A | _____MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAK |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61964 | T233 | Sugiyama | WDR5 BIG3 | DNPPVSFVKFSPNGKYILAAtLDNtLKLWDYSKGKCLKTYT |
| P61964 | T237 | Sugiyama | WDR5 BIG3 | VSFVKFSPNGKYILAAtLDNtLKLWDYSKGKCLKTYTGHKN |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62312 | T75 | Sugiyama | LSM6 | QLKNKyGDAFIRGNNVLyIstQKRRM_______________ |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62495 | T298 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | VKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMGAVE |
| P62701 | T159 | Sugiyama | RPS4X CCG2 RPS4 SCAR | LVtHDARTIRYPDPLIKVNDtIQIDLEtGKITDFIKFDtGN |
| P62701 | T166 | Sugiyama | RPS4X CCG2 RPS4 SCAR | TIRYPDPLIKVNDtIQIDLEtGKITDFIKFDtGNLCMVtGG |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62807 | S15 | GPS6|EPSD | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGKKRKRsRK |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62829 | S41 | Sugiyama | RPL23 | PVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVGDMV |
| P62829 | Y38 | Sugiyama | RPL23 | LGLPVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVG |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62888 | T83 | Sugiyama | RPL30 | yAMLAKtGVHHysGNNIELGtACGKyyRVCtLAIIDPGDsD |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63173 | T44 | Sugiyama | RPL38 | KIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPGL |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P78527 | T2645 | Sugiyama | PRKDC HYRC HYRC1 | LSARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstD |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | S9 | Sugiyama | RPL24 | ____________MKVELCsFsGyKIYPGHGRRYARTDGKVF |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84098 | Y124 | Sugiyama | RPL19 | RLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHIHK |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | T45 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | KMLAAKsADGsAPAGEGEGVtLQRNITLLNGVAIIVGTIIG |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02818 | T148 | Sugiyama | NUCB1 NUC | QVDHLNLLKQFEHLDPQNQHtFEARDLELLIQTATRDLAQY |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q04637 | T1119 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GGSGAKPSDAAsEAARPAtstLNRFsALQQAVPtEsTDNRR |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q05209 | T454 | Sugiyama | PTPN12 | LsFEIKKVPLQEGPKsFDGNtLLNRGHAIKIKsAsPCIADK |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T18 | SIGNOR|EPSD|PSP | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q06830 | T183 | SIGNOR|EPSD|PSP | PRDX1 PAGA PAGB TDPX2 | FQFtDKHGEVCPAGWKPGsDtIKPDVQKSKEyFSKQK____ |
| Q06830 | T90 | SIGNOR|EPSD|PSP | PRDX1 PAGA PAGB TDPX2 | NCQVIGASVDSHFCHLAWVNtPKKQGGLGPMNIPLVSDPKR |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T79 | Sugiyama | RPL18 | PPLsLsRMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07666 | T183 | Sugiyama | KHDRBS1 SAM68 | PVKQYPKFNFVGKILGPQGNtIKRLQEETGAKISVLGKGsM |
| Q07866 | T462 | Sugiyama | KLC1 KLC KNS2 | DGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKFEA |
| Q07866 | T466 | Sugiyama | KLC1 KLC KNS2 | FGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKFEAAETL |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q12778 | S212 | GPS6|SIGNOR|EPSD|PSP | FOXO1 FKHR FOXO1A | KSVPYFKDKGDSNSSAGWKNsIRHNLsLHSKFIRVQNEGTG |
| Q12778 | S218 | PSP | FOXO1 FKHR FOXO1A | KDKGDSNSSAGWKNsIRHNLsLHSKFIRVQNEGTGKssWWM |
| Q12778 | S234 | PSP | FOXO1 FKHR FOXO1A | RHNLsLHSKFIRVQNEGTGKssWWMLNPEGGKSGKsPRRRA |
| Q12778 | S235 | PSP | FOXO1 FKHR FOXO1A | HNLsLHSKFIRVQNEGTGKssWWMLNPEGGKSGKsPRRRAA |
| Q13043 | S288 | Sugiyama | STK4 KRS2 MST1 | QRAtAtQLLQHPFVRSAKGVsILRDLINEAMDVKLKRQESQ |
| Q13043 | S320 | Sugiyama | STK4 KRS2 MST1 | VKLKRQESQQREVDQDDEENsEEDEMDsGtMVRAVGDEMGt |
| Q13043 | S327 | SIGNOR|EPSD|Sugiyama | STK4 KRS2 MST1 | SQQREVDQDDEENsEEDEMDsGtMVRAVGDEMGtVRVASTM |
| Q13043 | S394 | Sugiyama | STK4 KRS2 MST1 | DEEEEGtMKRRDEtMQPAKPsFLEyFEQKEKENQINsFGKs |
| Q13043 | S40 | Sugiyama | STK4 KRS2 MST1 | DsLTKQPEEVFDVLEKLGEGsYGsVYKAIHKETGQIVAIKQ |
| Q13043 | S410 | Sugiyama | STK4 KRS2 MST1 | PAKPsFLEyFEQKEKENQINsFGKsVPGPLKNSsDWKIPQD |
| Q13043 | S414 | Sugiyama | STK4 KRS2 MST1 | sFLEyFEQKEKENQINsFGKsVPGPLKNSsDWKIPQDGDyE |
| Q13043 | S423 | Sugiyama | STK4 KRS2 MST1 | EKENQINsFGKsVPGPLKNSsDWKIPQDGDyEFLKsWtVED |
| Q13043 | S43 | Sugiyama | STK4 KRS2 MST1 | TKQPEEVFDVLEKLGEGsYGsVYKAIHKETGQIVAIKQVPV |
| Q13043 | S65 | Sugiyama | STK4 KRS2 MST1 | YKAIHKETGQIVAIKQVPVEsDLQEIIKEIsIMQQCDsPHV |
| Q13043 | S75 | Sugiyama | STK4 KRS2 MST1 | IVAIKQVPVEsDLQEIIKEIsIMQQCDsPHVVKYYGSYFKN |
| Q13043 | S82 | Sugiyama | STK4 KRS2 MST1 | PVEsDLQEIIKEIsIMQQCDsPHVVKYYGSYFKNTDLWIVM |
| Q13043 | T122 | Sugiyama | STK4 KRS2 MST1 | MEYCGAGSVSDIIRLRNKtLtEDEIAtILQStLKGLEYLHF |
| Q13043 | T128 | Sugiyama | STK4 KRS2 MST1 | GSVSDIIRLRNKtLtEDEIAtILQStLKGLEYLHFMRKIHR |
| Q13043 | T133 | Sugiyama | STK4 KRS2 MST1 | IIRLRNKtLtEDEIAtILQStLKGLEYLHFMRKIHRDIKAG |
| Q13043 | T159 | Sugiyama | STK4 KRS2 MST1 | YLHFMRKIHRDIKAGNILLNtEGHAKLADFGVAGQLtDtMA |
| Q13043 | T175 | Sugiyama | STK4 KRS2 MST1 | ILLNtEGHAKLADFGVAGQLtDtMAKRNtVIGtPFWMAPEV |
| Q13043 | T177 | SIGNOR|EPSD|Sugiyama | STK4 KRS2 MST1 | LNtEGHAKLADFGVAGQLtDtMAKRNtVIGtPFWMAPEVIQ |
| Q13043 | T183 | GPS6|SIGNOR|ELM|EPSD|PSP | STK4 KRS2 MST1 | AKLADFGVAGQLtDtMAKRNtVIGtPFWMAPEVIQEIGYNC |
| Q13043 | T187 | SIGNOR|EPSD | STK4 KRS2 MST1 | DFGVAGQLtDtMAKRNtVIGtPFWMAPEVIQEIGYNCVADI |
| Q13043 | T271 | Sugiyama | STK4 KRS2 MST1 | SDNFTDFVKQCLVKSPEQRAtAtQLLQHPFVRSAKGVsILR |
| Q13043 | T273 | Sugiyama | STK4 KRS2 MST1 | NFTDFVKQCLVKSPEQRAtAtQLLQHPFVRSAKGVsILRDL |
| Q13043 | T329 | Sugiyama | STK4 KRS2 MST1 | QREVDQDDEENsEEDEMDsGtMVRAVGDEMGtVRVASTMTD |
| Q13043 | T353 | EPSD|PSP | STK4 KRS2 MST1 | AVGDEMGtVRVASTMTDGANtMIEHDDTLPSQLGtMVINAE |
| Q13043 | T367 | EPSD|PSP | STK4 KRS2 MST1 | MTDGANtMIEHDDTLPSQLGtMVINAEDEEEEGtMKRRDEt |
| Q13043 | T387 | Sugiyama | STK4 KRS2 MST1 | tMVINAEDEEEEGtMKRRDEtMQPAKPsFLEyFEQKEKENQ |
| Q13043 | Y398 | Sugiyama | STK4 KRS2 MST1 | EGtMKRRDEtMQPAKPsFLEyFEQKEKENQINsFGKsVPGP |
| Q13043 | Y433 | Sugiyama | STK4 KRS2 MST1 | KsVPGPLKNSsDWKIPQDGDyEFLKsWtVEDLQKRLLALDP |
| Q13131 | T183 | PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13188 | S62 | Sugiyama | STK3 KRS1 MST2 | FKAIHKESGQVVAIKQVPVEsDLQEIIKEISIMQQCDSPyV |
| Q13188 | T156 | Sugiyama | STK3 KRS1 MST2 | YLHFMRKIHRDIKAGNILLNtEGHAKLADFGVAGQLtDtMA |
| Q13188 | T172 | Sugiyama | STK3 KRS1 MST2 | ILLNtEGHAKLADFGVAGQLtDtMAKRNtVIGTPFWMAPEV |
| Q13188 | T174 | Sugiyama | STK3 KRS1 MST2 | LNtEGHAKLADFGVAGQLtDtMAKRNtVIGTPFWMAPEVIQ |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | S360 | Sugiyama | UBAP2L KIAA0144 NICE4 | sMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLAAQHS |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14240 | S79 | Sugiyama | EIF4A2 DDX2B EIF4F | IQQRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEF |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | S113 | Sugiyama | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14247 | T145 | Sugiyama | CTTN EMS1 | FGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGKyGVQ |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14320 | T64 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | NIDKKFsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKER |
| Q14320 | T69 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | FsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKEREKQLA |
| Q14457 | T108 | EPSD|PSP | BECN1 GT197 | MMsTEsANsFTLIGEASDGGtMENLSRRLKVtGDLFDIMSG |
| Q14498 | T347 | Sugiyama | RBM39 HCC1 RNPC2 | TERtDAssAssFLDsDELERtGIDLGtTGRLQLMARLAEGT |
| Q14498 | T353 | Sugiyama | RBM39 HCC1 RNPC2 | ssAssFLDsDELERtGIDLGtTGRLQLMARLAEGTGLQIPP |
| Q14653 | T253 | EPSD|PSP | IRF3 | VGDRTLPGWPVTLPDPGMSLtDRGVMSYVRHVLSCLGGGLA |
| Q14653 | T75 | EPSD|PSP | IRF3 | QAWAEATGAYVPGRDKPDLPtWKRNFRsALNRKEGLRLAED |
| Q14677 | T211 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | NKSAFPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPERC |
| Q14677 | T215 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | FPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPERCsDsD |
| Q14697 | T229 | Sugiyama | GANAB G2AN KIAA0088 | DKPEETQGKAEKDEPGAWEEtFKTHSDSKPYGPMSVGLDFS |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q14978 | S693 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | EKTKKKRGsYRGGsIsVQVNsIKFDsE______________ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S94 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | RDKDTDKFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVD |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15208 | T444 | EPSD|PSP | STK38 NDR1 | ATSNHPETDYKNKDWVFINytYKRFEGLtARGAIPsYMKAA |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15293 | Y145 | Sugiyama | RCN1 RCN | KDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFK |
| Q15365 | T142 | Sugiyama | PCBP1 | EIREstGAQVQVAGDMLPNstERAITIAGVPQSVTECVKQI |
| Q15366 | T142 | Sugiyama | PCBP2 | EIREstGAQVQVAGDMLPNstERAITIAGIPQSIIECVKQI |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15560 | T254 | Sugiyama | TCEA2 | IRKAMTKEAIREHQMARTGGtQTDLFtCGKCRKKNCTYTQV |
| Q15648 | T1494 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | KsyQNsPssDDGIRPLPEYstEKHKKHKKEKKKVKDKDRDR |
| Q16181 | T426 | Sugiyama | SEPTIN7 CDC10 SEPT7 | DEKANWEAQQRILEQQNssRtLEKNKKKGKIF_________ |
| Q16543 | T118 | Sugiyama | CDC37 CDC37A | WEQKLEEMRKKEKSMPWNVDtLsKDGFSKsMVNtKPEKTEE |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q16630 | T404 | Sugiyama | CPSF6 CFIM68 | yGRPPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAI |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q16778 | S15 | GPS6|EPSD | H2BC21 H2BFQ HIST2H2BE | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q2VIR3 | T9 | Sugiyama | EIF2S3B | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5QNW6 | S15 | GPS6|EPSD | H2BC18 HIST2H2BF | ______MPDPAKSAPAPKKGsKKAVTKVQKKDGKKRKRSRK |
| Q5T3I0 | T271 | Sugiyama | GPATCH4 GPATC4 | KVsDEREGTTKGNEKEDAAGtsGLGELNSREQtNQSLRKGK |
| Q5UIP0 | T1715 | Sugiyama | RIF1 | GESSKIGIsDIssLsEKtFQtLECQHKRSRRVRRSKGCDCC |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q69YN2 | T535 | Sugiyama | CWF19L1 | KEDEETLARRFRKDFEPyDFtLDD_________________ |
| Q6DN03 | S15 | GPS6 | H2BC20P HIST2H2BC | ______MPEPAKFAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q6DRA6 | S15 | GPS6|EPSD | H2BC19P HIST2H2BD | ______MPEPAKFAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7L9L4 | T12 | GPS6|SIGNOR|EPSD|PSP | MOB1B MOB4A MOBKL1A | _________MsFLFGsRssKtFKPKKNIPEGSHQyELLKHA |
| Q7L9L4 | T35 | GPS6|SIGNOR|EPSD|PSP | MOB1B MOB4A MOBKL1A | PKKNIPEGSHQyELLKHAEAtLGsGNLRMAVMLPEGEDLNE |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z739 | T177 | Sugiyama | YTHDF3 | YPPSSLGRAITDGQAGFGNDtLSKVPGISsIEQGMTGLKIG |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86U42 | S225 | Sugiyama | PABPN1 PAB2 PABP2 | CDKFSGHPKGFAyIEFSDKEsVRTSLALDEsLFRGRQIKVI |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86UE4 | T194 | Sugiyama | MTDH AEG1 LYRIC | KAVQNssRHDGKEVDEGAWEtKISHREKRQQRKRDKVLtDs |
| Q86UE4 | T477 | Sugiyama | MTDH AEG1 LYRIC | stAQDtEELEKEIREDLPVNtsKTRPKQEKAFSLKtIstsD |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86VQ1 | S226 | Sugiyama | GLCCI1 | sCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQRSKQ |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IYD1 | T444 | Sugiyama | GSPT2 ERF3B | NRSIDGPIRLPIVDKYKDMGtVVLGKLESGSIFKGQQLVMM |
| Q8IZJ1 | T428 | GPS6|PSP | UNC5B P53RDL1 UNC5H2 UNQ1883/PRO4326 | TDITDSSAALTGGFHPVNFKtARPSNPQLLHPSVPPDLTAS |
| Q8N257 | S15 | GPS6|EPSD | H2BC26 H2BU1 HIST3H2BB | ______MPDPSKSAPAPKKGsKKAVTKAQKKDGKKRKRGRK |
| Q8N319 | S78 | Sugiyama | LINC03040 C6orf223 | QSVSGRKNSTSKDLVtLGASsLREERGHPLHPRHRKAVHLR |
| Q8N319 | T73 | Sugiyama | LINC03040 C6orf223 | LKAGRQSVSGRKNSTSKDLVtLGASsLREERGHPLHPRHRK |
| Q8TF09 | T67 | Sugiyama | DYNLRB2 DNCL2B DNLC2B ROBLD2 | HHLTMKAKSTVRDIDPQNDLtFLRIRSKKHEIMVAPDKEYL |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92499 | T302 | Sugiyama | DDX1 | FLPNAPKALIVEPSRELAEQtLNNIKQFKKYIDNPKLRELL |
| Q92522 | T55 | Sugiyama | H1-10 H1FX | KRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLAKIYTEAK |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S15 | GPS6|EPSD | H2BC9 H2BFJ HIST1H2BH | ______MPDPAKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q96G46 | T99 | Sugiyama | DUS3L | DGQtADGQtEEAAEPGEQLQtQKRARGQNKGRPHVKPTNYD |
| Q96GD4 | T232 | EPSD|PSP | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | GELKIADFGWSVHAPsLRRKtMCGtLDYLPPEMIEGRMHNE |
| Q96HC4 | T80 | Sugiyama | PDLIM5 ENH L9 | GMTHLEAQNKIKGCTGsLNMtLQRAsAAPKPEPVPVQKGEP |
| Q96IZ0 | T261 | Sugiyama | PAWR PAR4 | YsRTDRSGFPRYNRDANVsGtLVSSstLEKKIEDLEKEVVR |
| Q96JJ7 | T101 | Sugiyama | TMX3 KIAA1830 TXNDC10 | KMDATSYSSIASEFGVRGyPtIKLLKGDLAYNYRGPRTKDD |
| Q96MF7 | T70 | Sugiyama | NSMCE2 C8orf36 MMS21 | ESQTEVSSEYSMDKAMVEFAtLDRQLNHYVKAVQSTINHVK |
| Q99547 | T120 | Sugiyama | MPHOSPH6 MPP6 | VEDETVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEE |
| Q99547 | T124 | Sugiyama | MPHOSPH6 MPP6 | TVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEEDENG |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99627 | T158 | Sugiyama | COPS8 CSN8 | GLPVEEAVKGILEQGWQADstTRMVLPRKPVAGALDVsFNK |
| Q99729 | S242 | Sugiyama | HNRNPAB ABBP1 HNRPAB | SKCEIKVAQPKEVyQQQQyGsGGRGNRNRGNRGSGGGGGGG |
| Q99729 | T106 | Sugiyama | HNRNPAB ABBP1 HNRPAB | KDYFTKFGEVVDCtIKMDPNtGRSRGFGFILFKDAASVEKV |
| Q99729 | T99 | Sugiyama | HNRNPAB ABBP1 HNRPAB | DtsKKDLKDYFTKFGEVVDCtIKMDPNtGRSRGFGFILFKD |
| Q99832 | S59 | Sugiyama | CCT7 CCTH NIP7-1 | TLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTL |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q99877 | S15 | GPS6|EPSD | H2BC15 H2BFD HIST1H2BN | ______MPEPSKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q99879 | S15 | GPS6 | H2BC14 H2BFE HIST1H2BM | ______MPEPVKsAPVPKKGsKKAINKAQKKDGKKRKRSRK |
| Q99880 | S15 | GPS6|EPSD | H2BC13 H2BFC HIST1H2BL | ______MPELAKSAPAPKKGsKKAVTKAQKKDGKKRKRSRK |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BUJ2 | T113 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | SGPDGHYAMDNITRQNQFyDtQVIKQENESGyERRPLEMEQ |
| Q9BUJ2 | T507 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | CLNRLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRK |
| Q9BUJ2 | Y510 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | RLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIV |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9GZQ8 | T50 | SIGNOR|PSP | MAP1LC3B MAP1ALC3 | KIPVIIERYKGEKQLPVLDKtKFLVPDHVNMSELIKIIRRR |
| Q9H0B6 | S539 | Sugiyama | KLC2 | sEsDLEDVGPTAEWNGDGsGsLRRSGsFGKLRDALRRsSEM |
| Q9H0C5 | S273 | Sugiyama | BTBD1 C15orf1 NS5ATP8 | QRQQLPVTFGNKQKVLGKALsLIRFPLMTIEEFAAGPAQSG |
| Q9H0H5 | T251 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | EAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTE |
| Q9H0H5 | T260 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | PYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGtPQs |
| Q9H173 | T123 | Sugiyama | SIL1 UNQ545/PRO836 | KLQYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAE |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H173 | T127 | Sugiyama | SIL1 UNQ545/PRO836 | EDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMESs |
| Q9H173 | Y126 | Sugiyama | SIL1 UNQ545/PRO836 | YEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMES |
| Q9H2U1 | T179 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NRsyIDRDsEyLLQENEPDGtLDQKLLEDLQKKKNDLRYIE |
| Q9H3K6 | T27 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | YLREKLQRDLEAEHVEVEDttLNRCsCsFRVLVVSAKFEGK |
| Q9H444 | T85 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALQALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEV |
| Q9H444 | T88 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLKN |
| Q9H8S9 | T12 | SIGNOR | MOB1A C2orf6 MOB4B MOBK1B MOBKL1B | _________MsFLFssRssKtFKPKKNIPEGSHQyELLKHA |
| Q9H8S9 | T35 | SIGNOR|PSP | MOB1A C2orf6 MOB4B MOBK1B MOBKL1B | PKKNIPEGSHQyELLKHAEAtLGsGNLRQAVMLPEGEDLNE |
| Q9NP97 | T67 | Sugiyama | DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162 | HSFILKARStVRDIDPQNDLtFLRIRsKKNEIMVAPDKDYF |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NQE9 | T47 | Sugiyama | HINT3 | ssVGTCEAAGKsPEPKDyDstCVFCRIAGRQDPGTELLHCE |
| Q9NRM7 | S872 | SIGNOR | LATS2 KPM | DRLKTLEQRARKQHQRCLAHsLVGTPNYIAPEVLLRKGYTQ |
| Q9NRM7 | T1041 | SIGNOR | LATS2 KPM | AWDtLtsPNNKHPEHAFYEFtFRRFFDDNGyPFRCPKPSGA |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYF8 | T333 | Sugiyama | BCLAF1 BTF KIAA0164 | DEsRGRssFyPDGGDQETAKtGKFLKRFtDEEsRVFLLDRG |
| Q9NZZ3 | S16 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | _____MNRLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKIS |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P258 | T20 | Sugiyama | RCC2 KIAA1470 TD60 | _MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRKRERPE |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UHA3 | S68 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | KVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRELWNK |
| Q9UHA3 | T64 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | RNPRKVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRE |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UKS6 | T209 | Sugiyama | PACSIN3 | QERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQAFE |
| Q9UKX7 | T54 | Sugiyama | NUP50 NPAP60L PRO1146 | VLKNRAIKKAKRRNVGFEsDtGGAFKGFKGLVVPSGGGRFs |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UMX5 | T76 | Sugiyama | NENF CIR2 SPUF | GGEEEDQPIyLAVKGVVFDVtSGKEFYGRGAPYNALTGKDS |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y247 | T64 | Sugiyama | FAM50B X5L | QVDKRFSAHyDAVEAELKsstVGLVtLNDMKARQEALVRER |
| Q9Y247 | T69 | Sugiyama | FAM50B X5L | FSAHyDAVEAELKsstVGLVtLNDMKARQEALVRERERQLA |
| Q9Y281 | T88 | Sugiyama | CFL2 | YtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y295 | T62 | Sugiyama | DRG1 NEDD3 | LITPKGGGGGGPGEGFDVAKtGDARIGFVGFPSVGKSTLLS |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2K2 | T221 | PSP | SIK3 KIAA0999 QSK L19 | NIKIADFGFSNLFTPGQLLKtWCGSPPYAAPELFEGKEYDG |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2W1 | S232 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALK |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y383 | T17 | Sugiyama | LUC7L2 CGI-59 CGI-74 | ____MSAQAQMRAMLDQLMGtsRDGDttRQRIKFSDDRVCK |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 8.186224e-07 | 6.087 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.376174e-06 | 5.359 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.412673e-06 | 5.267 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.006560e-05 | 4.997 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.292279e-05 | 4.889 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.012832e-05 | 4.696 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.694985e-05 | 4.569 | 1 | 1 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.872909e-05 | 4.542 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.264156e-05 | 4.486 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.103283e-05 | 4.292 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.273663e-05 | 4.138 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.273663e-05 | 4.138 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.082682e-04 | 3.965 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.294285e-04 | 3.888 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.519019e-04 | 3.345 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.519019e-04 | 3.345 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.001785e-03 | 2.999 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.358279e-03 | 2.867 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.390911e-03 | 2.857 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.675274e-03 | 2.776 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.707428e-03 | 2.768 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.759346e-03 | 2.755 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.871901e-03 | 2.728 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.821117e-03 | 2.740 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.831964e-03 | 2.737 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.005361e-03 | 2.698 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.479607e-03 | 2.606 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.575557e-03 | 2.589 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.694714e-03 | 2.569 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.022329e-03 | 2.520 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.738379e-03 | 2.427 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.569179e-03 | 2.447 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.738379e-03 | 2.427 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.569179e-03 | 2.447 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.676288e-03 | 2.435 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.844087e-03 | 2.415 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.413485e-03 | 2.355 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.720926e-03 | 2.326 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.176083e-03 | 2.286 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.235743e-03 | 2.205 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.276668e-03 | 2.202 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.215277e-03 | 2.142 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.785051e-03 | 2.109 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.251803e-03 | 2.083 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.378843e-03 | 2.077 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.938095e-03 | 2.049 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.002582e-03 | 2.046 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.223966e-03 | 2.035 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.034263e-02 | 1.985 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.063479e-02 | 1.973 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.097530e-02 | 1.960 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.112404e-02 | 1.954 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.128610e-02 | 1.947 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.221452e-02 | 1.913 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.259344e-02 | 1.900 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.221452e-02 | 1.913 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.395687e-02 | 1.855 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.448108e-02 | 1.839 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.448108e-02 | 1.839 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.595186e-02 | 1.797 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.655856e-02 | 1.781 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.568456e-02 | 1.805 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.623626e-02 | 1.790 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.676522e-02 | 1.776 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.676522e-02 | 1.776 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.846323e-02 | 1.734 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.846323e-02 | 1.734 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.846323e-02 | 1.734 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.846323e-02 | 1.734 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.758338e-02 | 1.755 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.858694e-02 | 1.731 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.986727e-02 | 1.702 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.998298e-02 | 1.699 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.024190e-02 | 1.694 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.024190e-02 | 1.694 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.983496e-02 | 1.703 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.028718e-02 | 1.693 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.028718e-02 | 1.693 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.240677e-02 | 1.650 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.142121e-02 | 1.669 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.142121e-02 | 1.669 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.288529e-02 | 1.640 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.248640e-02 | 1.648 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.327304e-02 | 1.633 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.395192e-02 | 1.621 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.480532e-02 | 1.605 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.558948e-02 | 1.592 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.570170e-02 | 1.590 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.570170e-02 | 1.590 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.570170e-02 | 1.590 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.590791e-02 | 1.587 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.785499e-02 | 1.555 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.946254e-02 | 1.531 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.946254e-02 | 1.531 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.795020e-02 | 1.554 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.795020e-02 | 1.554 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.918763e-02 | 1.535 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.882072e-02 | 1.540 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.882072e-02 | 1.540 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.807437e-02 | 1.552 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.975181e-02 | 1.526 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.975181e-02 | 1.526 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.985794e-02 | 1.525 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.090027e-02 | 1.510 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.228040e-02 | 1.491 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.275790e-02 | 1.485 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.304410e-02 | 1.481 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.693948e-02 | 1.433 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.693948e-02 | 1.433 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.539838e-02 | 1.451 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.539838e-02 | 1.451 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.728606e-02 | 1.428 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.791170e-02 | 1.421 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.192318e-02 | 1.378 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.106353e-02 | 1.387 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.106353e-02 | 1.387 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.192318e-02 | 1.378 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.192318e-02 | 1.378 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.234951e-02 | 1.373 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.868394e-02 | 1.412 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.192318e-02 | 1.378 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.827739e-02 | 1.417 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.868394e-02 | 1.412 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.791170e-02 | 1.421 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.062965e-02 | 1.391 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.999948e-02 | 1.398 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.287079e-02 | 1.368 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.473907e-02 | 1.349 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.331318e-02 | 1.135 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.331318e-02 | 1.135 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.331318e-02 | 1.135 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.331318e-02 | 1.135 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.331318e-02 | 1.135 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.681554e-02 | 1.330 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.681554e-02 | 1.330 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.639654e-02 | 1.249 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.639654e-02 | 1.249 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.639654e-02 | 1.249 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.659188e-02 | 1.177 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.659188e-02 | 1.177 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.659188e-02 | 1.177 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.659188e-02 | 1.177 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.659188e-02 | 1.177 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.498229e-02 | 1.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.149016e-02 | 1.146 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.149016e-02 | 1.146 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.149016e-02 | 1.146 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.149016e-02 | 1.146 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.123843e-02 | 1.290 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.784144e-02 | 1.169 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.350109e-02 | 1.197 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.503721e-02 | 1.187 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.024793e-02 | 1.299 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.500060e-02 | 1.260 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.692397e-02 | 1.174 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.015046e-02 | 1.221 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.889773e-02 | 1.230 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.876331e-02 | 1.231 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.825149e-02 | 1.316 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.594477e-02 | 1.181 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.783109e-02 | 1.320 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.053425e-02 | 1.296 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.150774e-02 | 1.211 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.257430e-02 | 1.279 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.118183e-02 | 1.213 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.659188e-02 | 1.177 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.219270e-02 | 1.206 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.499235e-02 | 1.187 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.053425e-02 | 1.296 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.654722e-02 | 1.248 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.654722e-02 | 1.248 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.681554e-02 | 1.330 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.620432e-02 | 1.335 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.350109e-02 | 1.197 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.639654e-02 | 1.249 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.659188e-02 | 1.177 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.528623e-02 | 1.185 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.876331e-02 | 1.231 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.275345e-02 | 1.278 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.934394e-02 | 1.227 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.659188e-02 | 1.177 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.498229e-02 | 1.187 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.024793e-02 | 1.299 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.670211e-02 | 1.115 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.734245e-02 | 1.112 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.734245e-02 | 1.112 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.734245e-02 | 1.112 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.734245e-02 | 1.112 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.734245e-02 | 1.112 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.734245e-02 | 1.112 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.734245e-02 | 1.112 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.734245e-02 | 1.112 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.734245e-02 | 1.112 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.734245e-02 | 1.112 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.827765e-02 | 1.106 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.002905e-01 | 0.999 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.002905e-01 | 0.999 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.002905e-01 | 0.999 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.002905e-01 | 0.999 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.002905e-01 | 0.999 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.533502e-02 | 1.069 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.000776e-01 | 1.000 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.859272e-02 | 1.053 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.859272e-02 | 1.053 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.202271e-02 | 1.036 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.921475e-02 | 1.050 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.805787e-02 | 1.055 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.614051e-02 | 1.017 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.372157e-02 | 1.077 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.859272e-02 | 1.053 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.002905e-01 | 0.999 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.152289e-02 | 1.038 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.686842e-02 | 1.014 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.859272e-02 | 1.053 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.054213e-02 | 1.094 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.265209e-02 | 1.033 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.443400e-02 | 1.025 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.265209e-02 | 1.033 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.391596e-02 | 1.076 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.054213e-02 | 1.094 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.533502e-02 | 1.069 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.002184e-01 | 0.999 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.479954e-02 | 1.023 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.002184e-01 | 0.999 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.859272e-02 | 1.053 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.533502e-02 | 1.069 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.003255e-01 | 0.999 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.007038e-01 | 0.997 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.007038e-01 | 0.997 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.046051e-01 | 0.980 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.050198e-01 | 0.979 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.079320e-01 | 0.967 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.079320e-01 | 0.967 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.079320e-01 | 0.967 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.079320e-01 | 0.967 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.079320e-01 | 0.967 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.079320e-01 | 0.967 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.080230e-01 | 0.966 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.080230e-01 | 0.966 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.096877e-01 | 0.960 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.412597e-01 | 0.850 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.412597e-01 | 0.850 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.412597e-01 | 0.850 | 0 | 0 |
| Glycogen storage disease type II (GAA) | R-HSA-5357609 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.412597e-01 | 0.850 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.412597e-01 | 0.850 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.412597e-01 | 0.850 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.412597e-01 | 0.850 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.412597e-01 | 0.850 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.248355e-01 | 0.904 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.248355e-01 | 0.904 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.160551e-01 | 0.935 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.327568e-01 | 0.877 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.414038e-01 | 0.850 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.123489e-01 | 0.949 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.123867e-01 | 0.949 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.160551e-01 | 0.935 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.177472e-01 | 0.929 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.412597e-01 | 0.850 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.123867e-01 | 0.949 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.123867e-01 | 0.949 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.123867e-01 | 0.949 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.123867e-01 | 0.949 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.248355e-01 | 0.904 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.375937e-01 | 0.861 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.243035e-01 | 0.906 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.134440e-01 | 0.945 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.160551e-01 | 0.935 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.205470e-01 | 0.919 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.414038e-01 | 0.850 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.243035e-01 | 0.906 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.134440e-01 | 0.945 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.456953e-01 | 0.837 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.170114e-01 | 0.932 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.170114e-01 | 0.932 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.128375e-01 | 0.948 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.429874e-01 | 0.845 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.123867e-01 | 0.949 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.327568e-01 | 0.877 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.471855e-01 | 0.832 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.190405e-01 | 0.924 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.375937e-01 | 0.861 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.396478e-01 | 0.855 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.128375e-01 | 0.948 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.255855e-01 | 0.901 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.321730e-01 | 0.879 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.493369e-01 | 0.826 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.493369e-01 | 0.826 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.493369e-01 | 0.826 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.733441e-01 | 0.761 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.042317e-01 | 0.690 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.042317e-01 | 0.690 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.042317e-01 | 0.690 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.042317e-01 | 0.690 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.339670e-01 | 0.631 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.625929e-01 | 0.581 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.625929e-01 | 0.581 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.625929e-01 | 0.581 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.625929e-01 | 0.581 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.506210e-01 | 0.822 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.506210e-01 | 0.822 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.901508e-01 | 0.537 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.638795e-01 | 0.785 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.638795e-01 | 0.785 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.773338e-01 | 0.751 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.166804e-01 | 0.499 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.166804e-01 | 0.499 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.166804e-01 | 0.499 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.166804e-01 | 0.499 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.166804e-01 | 0.499 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.909509e-01 | 0.719 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.909509e-01 | 0.719 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.047000e-01 | 0.689 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.047000e-01 | 0.689 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.422201e-01 | 0.466 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.422201e-01 | 0.466 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.422201e-01 | 0.466 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.185522e-01 | 0.660 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.502332e-01 | 0.823 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.502332e-01 | 0.823 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.668067e-01 | 0.436 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.668067e-01 | 0.436 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.464606e-01 | 0.608 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.904758e-01 | 0.408 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.064103e-01 | 0.685 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.064103e-01 | 0.685 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.884841e-01 | 0.540 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.884841e-01 | 0.540 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.132615e-01 | 0.384 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.360667e-01 | 0.627 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.163731e-01 | 0.500 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.351967e-01 | 0.361 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.351967e-01 | 0.361 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.127410e-01 | 0.672 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.286642e-01 | 0.641 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.576863e-01 | 0.446 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.847251e-01 | 0.415 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.847251e-01 | 0.415 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.863773e-01 | 0.543 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.863773e-01 | 0.543 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.980597e-01 | 0.400 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.381576e-01 | 0.623 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.117505e-01 | 0.506 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.590034e-01 | 0.445 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.372149e-01 | 0.359 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.084643e-01 | 0.511 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.998669e-01 | 0.398 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.715068e-01 | 0.430 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.715068e-01 | 0.430 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.885671e-01 | 0.411 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.475934e-01 | 0.349 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.968729e-01 | 0.706 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.523427e-01 | 0.817 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.176631e-01 | 0.662 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.777025e-01 | 0.750 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.578808e-01 | 0.589 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.929656e-01 | 0.406 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.112584e-01 | 0.386 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.530726e-01 | 0.597 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.980597e-01 | 0.400 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.750130e-01 | 0.426 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.909509e-01 | 0.719 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.559334e-01 | 0.807 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.750130e-01 | 0.426 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.112584e-01 | 0.386 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.871487e-01 | 0.728 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.448736e-01 | 0.611 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.099783e-01 | 0.387 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.613276e-01 | 0.583 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.532758e-01 | 0.596 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.185522e-01 | 0.660 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.464606e-01 | 0.608 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.884841e-01 | 0.540 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.855109e-01 | 0.414 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.280879e-01 | 0.484 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.300375e-01 | 0.366 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.683938e-01 | 0.774 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.482407e-01 | 0.458 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.280879e-01 | 0.484 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.399756e-01 | 0.357 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.162042e-01 | 0.665 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.243127e-01 | 0.372 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.521729e-01 | 0.598 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.461151e-01 | 0.609 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.967216e-01 | 0.706 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.042317e-01 | 0.690 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.339670e-01 | 0.631 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.422201e-01 | 0.466 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.185522e-01 | 0.660 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.185522e-01 | 0.660 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.871487e-01 | 0.728 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.372149e-01 | 0.359 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.084643e-01 | 0.511 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.352885e-01 | 0.628 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.884258e-01 | 0.411 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.011132e-01 | 0.521 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.287998e-01 | 0.483 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.399756e-01 | 0.357 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.625929e-01 | 0.581 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.166804e-01 | 0.499 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.921297e-01 | 0.716 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.766136e-01 | 0.558 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.980597e-01 | 0.400 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.112584e-01 | 0.386 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.677086e-01 | 0.572 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.819264e-01 | 0.550 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.584231e-01 | 0.588 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.324808e-01 | 0.634 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.487129e-01 | 0.458 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.498465e-01 | 0.347 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.759645e-01 | 0.559 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.339670e-01 | 0.631 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.625929e-01 | 0.581 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.625929e-01 | 0.581 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 2.625929e-01 | 0.581 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.625929e-01 | 0.581 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.638795e-01 | 0.785 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.773338e-01 | 0.751 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.166804e-01 | 0.499 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.166804e-01 | 0.499 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.422201e-01 | 0.466 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.422201e-01 | 0.466 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.422201e-01 | 0.466 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.668067e-01 | 0.436 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.668067e-01 | 0.436 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.683938e-01 | 0.774 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.904758e-01 | 0.408 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.967216e-01 | 0.706 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.351967e-01 | 0.361 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.351967e-01 | 0.361 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.351967e-01 | 0.361 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.528988e-01 | 0.816 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.576863e-01 | 0.446 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.712639e-01 | 0.430 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.847251e-01 | 0.415 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.112584e-01 | 0.386 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.631296e-01 | 0.440 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.362096e-01 | 0.360 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.816665e-01 | 0.741 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.339670e-01 | 0.631 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.663978e-01 | 0.574 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.663978e-01 | 0.574 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.747010e-01 | 0.561 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.506210e-01 | 0.822 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.166804e-01 | 0.499 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.166804e-01 | 0.499 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.668067e-01 | 0.436 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.904758e-01 | 0.408 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.132615e-01 | 0.384 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.897081e-01 | 0.409 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.744831e-01 | 0.561 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.064103e-01 | 0.685 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.300375e-01 | 0.366 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.314569e-01 | 0.636 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.752213e-01 | 0.560 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.113598e-01 | 0.675 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.024531e-01 | 0.519 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.259222e-01 | 0.646 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.733441e-01 | 0.761 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 2.339670e-01 | 0.631 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.625929e-01 | 0.581 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.625929e-01 | 0.581 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.166804e-01 | 0.499 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.166804e-01 | 0.499 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.422201e-01 | 0.466 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.422201e-01 | 0.466 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.422201e-01 | 0.466 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.668067e-01 | 0.436 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.668067e-01 | 0.436 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.871487e-01 | 0.728 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.871487e-01 | 0.728 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.904758e-01 | 0.408 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.598770e-01 | 0.796 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.576863e-01 | 0.446 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.010440e-01 | 0.697 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.527596e-01 | 0.816 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.791813e-01 | 0.747 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.083486e-01 | 0.389 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.162042e-01 | 0.665 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.502332e-01 | 0.823 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.920152e-01 | 0.717 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.568714e-01 | 0.590 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.638795e-01 | 0.785 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.744640e-01 | 0.758 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 2.868669e-01 | 0.542 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.868669e-01 | 0.542 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.462284e-01 | 0.609 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.733441e-01 | 0.761 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.901508e-01 | 0.537 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.666854e-01 | 0.778 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.324808e-01 | 0.634 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.042317e-01 | 0.690 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.042317e-01 | 0.690 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.339670e-01 | 0.631 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.339670e-01 | 0.631 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.625929e-01 | 0.581 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.625929e-01 | 0.581 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.625929e-01 | 0.581 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.901508e-01 | 0.537 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.773338e-01 | 0.751 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.422201e-01 | 0.466 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.422201e-01 | 0.466 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.324808e-01 | 0.634 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.939897e-01 | 0.712 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.308773e-01 | 0.366 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.905376e-01 | 0.408 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.976945e-01 | 0.704 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.701661e-01 | 0.769 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.372149e-01 | 0.359 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.024531e-01 | 0.519 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.604686e-01 | 0.584 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.904758e-01 | 0.408 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.696333e-01 | 0.569 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.430034e-01 | 0.614 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.216494e-01 | 0.493 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.827659e-01 | 0.738 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.625929e-01 | 0.581 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.625929e-01 | 0.581 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.625929e-01 | 0.581 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.506210e-01 | 0.822 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.901508e-01 | 0.537 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.901508e-01 | 0.537 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.901508e-01 | 0.537 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.909509e-01 | 0.719 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.967216e-01 | 0.706 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.132615e-01 | 0.384 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.132615e-01 | 0.384 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.132615e-01 | 0.384 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.458643e-01 | 0.461 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.300800e-01 | 0.366 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.759645e-01 | 0.559 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.440036e-01 | 0.463 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.576863e-01 | 0.446 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.638795e-01 | 0.785 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.464606e-01 | 0.608 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.967216e-01 | 0.706 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.663978e-01 | 0.574 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.576863e-01 | 0.446 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.948055e-01 | 0.530 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.773338e-01 | 0.751 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.904758e-01 | 0.408 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.904758e-01 | 0.408 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.482407e-01 | 0.458 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.164805e-01 | 0.500 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 2.185522e-01 | 0.660 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.289324e-01 | 0.368 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.232577e-01 | 0.651 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.016897e-01 | 0.695 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.884841e-01 | 0.540 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.365643e-01 | 0.626 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.286642e-01 | 0.641 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.884841e-01 | 0.540 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.132615e-01 | 0.384 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.440036e-01 | 0.463 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.280879e-01 | 0.484 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.004993e-01 | 0.522 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.932974e-01 | 0.405 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.177677e-01 | 0.498 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.300375e-01 | 0.366 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.413477e-01 | 0.617 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.260931e-01 | 0.646 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.998669e-01 | 0.398 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.260931e-01 | 0.646 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.948055e-01 | 0.530 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.502332e-01 | 0.823 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.744831e-01 | 0.561 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.260931e-01 | 0.646 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.360667e-01 | 0.627 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.779849e-01 | 0.556 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.929656e-01 | 0.406 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.286642e-01 | 0.641 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 3.487129e-01 | 0.458 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.562286e-01 | 0.591 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.132615e-01 | 0.384 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.971493e-01 | 0.527 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.132615e-01 | 0.384 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.163240e-01 | 0.381 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.971493e-01 | 0.527 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.170915e-01 | 0.499 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.300800e-01 | 0.366 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.904758e-01 | 0.408 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.953761e-01 | 0.530 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.884258e-01 | 0.411 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.744831e-01 | 0.561 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.422201e-01 | 0.466 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.399756e-01 | 0.357 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.308773e-01 | 0.366 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.549220e-01 | 0.450 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.324808e-01 | 0.634 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.302281e-01 | 0.481 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.712639e-01 | 0.430 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.499583e-01 | 0.347 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.499583e-01 | 0.347 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.521354e-01 | 0.345 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.563132e-01 | 0.341 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.563132e-01 | 0.341 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.563132e-01 | 0.341 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.563132e-01 | 0.341 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.563132e-01 | 0.341 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.563132e-01 | 0.341 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.563132e-01 | 0.341 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.563132e-01 | 0.341 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.563132e-01 | 0.341 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.563132e-01 | 0.341 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.563132e-01 | 0.341 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.563132e-01 | 0.341 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.563132e-01 | 0.341 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.563132e-01 | 0.341 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.567974e-01 | 0.340 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.625367e-01 | 0.335 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.625367e-01 | 0.335 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.641532e-01 | 0.333 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.667128e-01 | 0.331 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.693700e-01 | 0.328 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.693700e-01 | 0.328 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.749445e-01 | 0.323 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.749445e-01 | 0.323 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.749445e-01 | 0.323 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.754047e-01 | 0.323 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.766414e-01 | 0.322 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.766414e-01 | 0.322 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 4.766414e-01 | 0.322 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.766414e-01 | 0.322 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.766414e-01 | 0.322 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.766414e-01 | 0.322 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.766414e-01 | 0.322 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.766414e-01 | 0.322 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.766414e-01 | 0.322 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.766414e-01 | 0.322 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.766414e-01 | 0.322 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.790147e-01 | 0.320 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.840766e-01 | 0.315 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.871771e-01 | 0.312 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.871771e-01 | 0.312 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.885765e-01 | 0.311 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.885765e-01 | 0.311 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.886514e-01 | 0.311 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.943902e-01 | 0.306 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.962107e-01 | 0.304 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.962107e-01 | 0.304 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.962107e-01 | 0.304 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.962107e-01 | 0.304 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.980521e-01 | 0.303 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.980521e-01 | 0.303 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.980521e-01 | 0.303 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.047263e-01 | 0.297 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.052776e-01 | 0.296 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.074384e-01 | 0.295 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.110999e-01 | 0.291 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.150495e-01 | 0.288 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.150495e-01 | 0.288 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.150495e-01 | 0.288 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.150495e-01 | 0.288 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.150495e-01 | 0.288 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.150495e-01 | 0.288 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.150495e-01 | 0.288 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.150495e-01 | 0.288 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.150495e-01 | 0.288 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.150495e-01 | 0.288 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.150495e-01 | 0.288 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.150495e-01 | 0.288 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.150495e-01 | 0.288 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.167324e-01 | 0.287 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.182596e-01 | 0.285 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.205739e-01 | 0.284 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.227833e-01 | 0.282 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.227833e-01 | 0.282 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.227833e-01 | 0.282 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.227833e-01 | 0.282 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.331849e-01 | 0.273 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.331849e-01 | 0.273 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.331849e-01 | 0.273 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.331849e-01 | 0.273 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.331849e-01 | 0.273 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.331849e-01 | 0.273 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.331849e-01 | 0.273 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.331849e-01 | 0.273 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.342778e-01 | 0.272 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.342778e-01 | 0.272 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.342778e-01 | 0.272 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.342778e-01 | 0.272 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.342778e-01 | 0.272 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.385230e-01 | 0.269 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.440347e-01 | 0.264 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.440347e-01 | 0.264 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.440347e-01 | 0.264 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.443541e-01 | 0.264 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.455810e-01 | 0.263 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.455810e-01 | 0.263 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.455810e-01 | 0.263 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.506432e-01 | 0.259 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.506432e-01 | 0.259 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.506432e-01 | 0.259 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.506432e-01 | 0.259 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.506432e-01 | 0.259 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.506432e-01 | 0.259 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.524761e-01 | 0.258 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.529344e-01 | 0.257 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.566912e-01 | 0.254 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.579030e-01 | 0.253 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.674495e-01 | 0.246 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.674495e-01 | 0.246 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.674495e-01 | 0.246 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.674495e-01 | 0.246 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.674495e-01 | 0.246 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.674495e-01 | 0.246 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.674495e-01 | 0.246 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.674495e-01 | 0.246 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.676071e-01 | 0.246 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.676071e-01 | 0.246 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.676071e-01 | 0.246 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.676071e-01 | 0.246 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.676071e-01 | 0.246 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.704205e-01 | 0.244 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.704205e-01 | 0.244 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.783275e-01 | 0.238 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.783275e-01 | 0.238 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.790033e-01 | 0.237 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.790033e-01 | 0.237 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.813875e-01 | 0.236 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.836283e-01 | 0.234 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.836283e-01 | 0.234 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.836283e-01 | 0.234 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.836283e-01 | 0.234 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.836283e-01 | 0.234 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.836283e-01 | 0.234 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.857649e-01 | 0.232 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.874775e-01 | 0.231 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.888520e-01 | 0.230 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.935087e-01 | 0.227 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.958416e-01 | 0.225 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.991801e-01 | 0.222 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.991801e-01 | 0.222 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.991801e-01 | 0.222 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.992029e-01 | 0.222 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.992029e-01 | 0.222 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.992029e-01 | 0.222 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.992029e-01 | 0.222 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.992029e-01 | 0.222 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.992029e-01 | 0.222 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.992029e-01 | 0.222 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.022339e-01 | 0.220 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.071305e-01 | 0.217 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.093118e-01 | 0.215 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.093118e-01 | 0.215 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.093118e-01 | 0.215 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.093118e-01 | 0.215 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.093118e-01 | 0.215 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.093118e-01 | 0.215 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.093118e-01 | 0.215 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.122353e-01 | 0.213 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.122353e-01 | 0.213 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.141959e-01 | 0.212 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.141959e-01 | 0.212 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.141959e-01 | 0.212 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.141959e-01 | 0.212 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.141959e-01 | 0.212 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.141959e-01 | 0.212 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.162420e-01 | 0.210 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.166513e-01 | 0.210 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.286289e-01 | 0.202 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.286289e-01 | 0.202 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.286289e-01 | 0.202 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.286289e-01 | 0.202 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.286289e-01 | 0.202 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.286289e-01 | 0.202 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.286289e-01 | 0.202 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.286289e-01 | 0.202 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.286289e-01 | 0.202 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.289873e-01 | 0.201 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.361417e-01 | 0.196 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.375281e-01 | 0.196 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.376286e-01 | 0.195 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.385322e-01 | 0.195 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.425227e-01 | 0.192 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.425227e-01 | 0.192 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.425227e-01 | 0.192 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.425227e-01 | 0.192 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.425227e-01 | 0.192 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.425227e-01 | 0.192 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.425227e-01 | 0.192 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.425227e-01 | 0.192 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.478832e-01 | 0.189 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.478832e-01 | 0.189 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.486711e-01 | 0.188 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.507732e-01 | 0.187 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.512313e-01 | 0.186 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.525125e-01 | 0.185 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.558976e-01 | 0.183 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.558976e-01 | 0.183 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.558976e-01 | 0.183 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.570413e-01 | 0.182 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.570413e-01 | 0.182 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.570413e-01 | 0.182 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.576364e-01 | 0.182 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.586857e-01 | 0.181 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.660080e-01 | 0.177 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.660080e-01 | 0.177 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.660245e-01 | 0.177 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.687729e-01 | 0.175 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.687729e-01 | 0.175 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.687729e-01 | 0.175 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.687729e-01 | 0.175 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.687729e-01 | 0.175 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.700289e-01 | 0.174 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.711156e-01 | 0.173 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.732478e-01 | 0.172 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.747846e-01 | 0.171 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.747846e-01 | 0.171 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.748336e-01 | 0.171 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.780664e-01 | 0.169 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.806466e-01 | 0.167 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.811672e-01 | 0.167 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.811672e-01 | 0.167 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.848624e-01 | 0.164 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.873480e-01 | 0.163 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.917747e-01 | 0.160 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 6.917747e-01 | 0.160 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.919741e-01 | 0.160 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.930984e-01 | 0.159 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.930984e-01 | 0.159 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.930984e-01 | 0.159 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.930984e-01 | 0.159 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.930984e-01 | 0.159 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.930984e-01 | 0.159 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.930984e-01 | 0.159 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 6.930984e-01 | 0.159 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.930984e-01 | 0.159 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.930984e-01 | 0.159 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.930984e-01 | 0.159 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.930984e-01 | 0.159 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.942253e-01 | 0.158 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.945482e-01 | 0.158 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.999918e-01 | 0.155 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.004707e-01 | 0.155 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.045838e-01 | 0.152 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.045838e-01 | 0.152 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.045838e-01 | 0.152 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.045838e-01 | 0.152 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.045838e-01 | 0.152 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.045838e-01 | 0.152 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.045838e-01 | 0.152 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.045838e-01 | 0.152 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.076362e-01 | 0.150 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.079190e-01 | 0.150 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.080264e-01 | 0.150 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.080264e-01 | 0.150 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.080264e-01 | 0.150 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.103472e-01 | 0.149 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.156401e-01 | 0.145 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.156401e-01 | 0.145 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.156401e-01 | 0.145 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.156401e-01 | 0.145 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.156401e-01 | 0.145 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.156401e-01 | 0.145 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.158805e-01 | 0.145 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.205917e-01 | 0.142 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.233313e-01 | 0.141 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.235565e-01 | 0.141 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.235565e-01 | 0.141 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.235565e-01 | 0.141 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.235565e-01 | 0.141 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.262832e-01 | 0.139 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.262832e-01 | 0.139 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.262832e-01 | 0.139 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.310566e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.310566e-01 | 0.136 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.310566e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.310566e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.310566e-01 | 0.136 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.310566e-01 | 0.136 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 7.310566e-01 | 0.136 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.365286e-01 | 0.133 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.365286e-01 | 0.133 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.365286e-01 | 0.133 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.365286e-01 | 0.133 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.383833e-01 | 0.132 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.383833e-01 | 0.132 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.383833e-01 | 0.132 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.386110e-01 | 0.132 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.386110e-01 | 0.132 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.391818e-01 | 0.131 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 7.403983e-01 | 0.131 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.451565e-01 | 0.128 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.451565e-01 | 0.128 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.455390e-01 | 0.128 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.455390e-01 | 0.128 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.461181e-01 | 0.127 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.463911e-01 | 0.127 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.463911e-01 | 0.127 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.463911e-01 | 0.127 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.463911e-01 | 0.127 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.463911e-01 | 0.127 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.505896e-01 | 0.125 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.510216e-01 | 0.124 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.522389e-01 | 0.124 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.551539e-01 | 0.122 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.551539e-01 | 0.122 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.558850e-01 | 0.122 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.558850e-01 | 0.122 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.558850e-01 | 0.122 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.558850e-01 | 0.122 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.558850e-01 | 0.122 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.565596e-01 | 0.121 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.567781e-01 | 0.121 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.593476e-01 | 0.120 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.650241e-01 | 0.116 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.650241e-01 | 0.116 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.650241e-01 | 0.116 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.658478e-01 | 0.116 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.660058e-01 | 0.116 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.679687e-01 | 0.115 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.738215e-01 | 0.111 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 7.738215e-01 | 0.111 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.738215e-01 | 0.111 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.738215e-01 | 0.111 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.738215e-01 | 0.111 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.738215e-01 | 0.111 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.738215e-01 | 0.111 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.738215e-01 | 0.111 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.738215e-01 | 0.111 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.788836e-01 | 0.109 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.794564e-01 | 0.108 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.794564e-01 | 0.108 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.794564e-01 | 0.108 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.822901e-01 | 0.107 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.822901e-01 | 0.107 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.822901e-01 | 0.107 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.822901e-01 | 0.107 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.822901e-01 | 0.107 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.830793e-01 | 0.106 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.831028e-01 | 0.106 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.839643e-01 | 0.106 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.839643e-01 | 0.106 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.850273e-01 | 0.105 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.872597e-01 | 0.104 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.904421e-01 | 0.102 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.904421e-01 | 0.102 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.904421e-01 | 0.102 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.904421e-01 | 0.102 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.904421e-01 | 0.102 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.904421e-01 | 0.102 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.904421e-01 | 0.102 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.904421e-01 | 0.102 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.910592e-01 | 0.102 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.941140e-01 | 0.100 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.941140e-01 | 0.100 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.953875e-01 | 0.099 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.969414e-01 | 0.099 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.969414e-01 | 0.099 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.982894e-01 | 0.098 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.982894e-01 | 0.098 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.982894e-01 | 0.098 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.982894e-01 | 0.098 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.993011e-01 | 0.097 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.993593e-01 | 0.097 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.026766e-01 | 0.095 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 8.026766e-01 | 0.095 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.026766e-01 | 0.095 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.029170e-01 | 0.095 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.038633e-01 | 0.095 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.038633e-01 | 0.095 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.058432e-01 | 0.094 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.058432e-01 | 0.094 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.058432e-01 | 0.094 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.058432e-01 | 0.094 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.065048e-01 | 0.093 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.082675e-01 | 0.092 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.082675e-01 | 0.092 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.131146e-01 | 0.090 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.131146e-01 | 0.090 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.131146e-01 | 0.090 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.131146e-01 | 0.090 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.131146e-01 | 0.090 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.131146e-01 | 0.090 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.131146e-01 | 0.090 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.131146e-01 | 0.090 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.131146e-01 | 0.090 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.137170e-01 | 0.090 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.137170e-01 | 0.090 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.143205e-01 | 0.089 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.190277e-01 | 0.087 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.190277e-01 | 0.087 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.201142e-01 | 0.086 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.201142e-01 | 0.086 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.201142e-01 | 0.086 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.201142e-01 | 0.086 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.201142e-01 | 0.086 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.201142e-01 | 0.086 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.268519e-01 | 0.083 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.268519e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.268519e-01 | 0.083 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.292439e-01 | 0.081 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.292439e-01 | 0.081 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.304663e-01 | 0.081 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.333377e-01 | 0.079 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.333377e-01 | 0.079 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.333377e-01 | 0.079 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.333377e-01 | 0.079 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.333377e-01 | 0.079 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.333377e-01 | 0.079 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.349758e-01 | 0.078 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.389379e-01 | 0.076 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.389379e-01 | 0.076 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.389379e-01 | 0.076 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.395810e-01 | 0.076 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.395810e-01 | 0.076 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.445387e-01 | 0.073 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 8.455907e-01 | 0.073 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.455907e-01 | 0.073 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.455907e-01 | 0.073 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.455907e-01 | 0.073 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.485112e-01 | 0.071 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.507754e-01 | 0.070 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.507754e-01 | 0.070 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.513756e-01 | 0.070 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.513756e-01 | 0.070 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.513756e-01 | 0.070 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.513756e-01 | 0.070 | 0 | 0 |
| Defensins | R-HSA-1461973 | 8.569442e-01 | 0.067 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.569442e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.569442e-01 | 0.067 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.569442e-01 | 0.067 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.623044e-01 | 0.064 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.623044e-01 | 0.064 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.623044e-01 | 0.064 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.623044e-01 | 0.064 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.623044e-01 | 0.064 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.653407e-01 | 0.063 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.674641e-01 | 0.062 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.674641e-01 | 0.062 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.674641e-01 | 0.062 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.674641e-01 | 0.062 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.674641e-01 | 0.062 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.674641e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.674641e-01 | 0.062 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.724308e-01 | 0.059 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.724308e-01 | 0.059 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.724308e-01 | 0.059 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.724308e-01 | 0.059 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.752681e-01 | 0.058 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.752681e-01 | 0.058 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.766663e-01 | 0.057 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.772116e-01 | 0.057 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.803141e-01 | 0.055 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.803141e-01 | 0.055 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.818136e-01 | 0.055 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.818136e-01 | 0.055 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.818136e-01 | 0.055 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.818136e-01 | 0.055 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.838620e-01 | 0.054 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.843829e-01 | 0.053 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.862433e-01 | 0.052 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.862433e-01 | 0.052 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.862433e-01 | 0.052 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.874550e-01 | 0.052 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.905073e-01 | 0.050 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.906677e-01 | 0.050 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.933568e-01 | 0.049 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.939301e-01 | 0.049 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.939301e-01 | 0.049 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.946117e-01 | 0.048 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.946117e-01 | 0.048 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.961321e-01 | 0.048 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.971018e-01 | 0.047 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.985625e-01 | 0.046 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.985625e-01 | 0.046 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.985625e-01 | 0.046 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.985625e-01 | 0.046 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.985625e-01 | 0.046 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.000664e-01 | 0.046 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.001851e-01 | 0.046 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.001851e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.023654e-01 | 0.045 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.023654e-01 | 0.045 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.031821e-01 | 0.044 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.040727e-01 | 0.044 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.047519e-01 | 0.043 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.052461e-01 | 0.043 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.060260e-01 | 0.043 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.060260e-01 | 0.043 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.089257e-01 | 0.041 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.095495e-01 | 0.041 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.116765e-01 | 0.040 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.116765e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.129411e-01 | 0.040 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.143493e-01 | 0.039 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.169461e-01 | 0.038 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.175254e-01 | 0.037 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.179934e-01 | 0.037 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.193482e-01 | 0.037 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.219194e-01 | 0.035 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.219194e-01 | 0.035 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.223729e-01 | 0.035 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.230968e-01 | 0.035 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.266113e-01 | 0.033 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.266113e-01 | 0.033 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.280869e-01 | 0.032 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.280869e-01 | 0.032 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.280869e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.280869e-01 | 0.032 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.289863e-01 | 0.032 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.306287e-01 | 0.031 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.307844e-01 | 0.031 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.307844e-01 | 0.031 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.307844e-01 | 0.031 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.307844e-01 | 0.031 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.310365e-01 | 0.031 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.310783e-01 | 0.031 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.333809e-01 | 0.030 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.333809e-01 | 0.030 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.341047e-01 | 0.030 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.341047e-01 | 0.030 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.343345e-01 | 0.029 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.352085e-01 | 0.029 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.352085e-01 | 0.029 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.358802e-01 | 0.029 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.358802e-01 | 0.029 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.382858e-01 | 0.028 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.406013e-01 | 0.027 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.410210e-01 | 0.026 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.410210e-01 | 0.026 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.410210e-01 | 0.026 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.428149e-01 | 0.026 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.428301e-01 | 0.026 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.428301e-01 | 0.026 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.433517e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.437634e-01 | 0.025 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.441885e-01 | 0.025 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.446172e-01 | 0.025 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.449754e-01 | 0.025 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.459137e-01 | 0.024 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.475139e-01 | 0.023 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.480042e-01 | 0.023 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.490278e-01 | 0.023 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.493261e-01 | 0.023 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.509409e-01 | 0.022 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.509409e-01 | 0.022 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.509409e-01 | 0.022 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.516487e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.527822e-01 | 0.021 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.527822e-01 | 0.021 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.545546e-01 | 0.020 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.545546e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.562606e-01 | 0.019 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.562606e-01 | 0.019 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.570202e-01 | 0.019 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.579026e-01 | 0.019 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.579026e-01 | 0.019 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.580204e-01 | 0.019 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.583055e-01 | 0.018 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.603418e-01 | 0.018 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.610042e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.621780e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.624684e-01 | 0.017 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.625423e-01 | 0.017 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.634875e-01 | 0.016 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.638777e-01 | 0.016 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.652342e-01 | 0.015 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.652342e-01 | 0.015 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.665398e-01 | 0.015 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.665398e-01 | 0.015 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.673624e-01 | 0.014 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.690060e-01 | 0.014 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.701702e-01 | 0.013 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.701702e-01 | 0.013 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.719247e-01 | 0.012 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.732443e-01 | 0.012 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.734072e-01 | 0.012 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.753680e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.766711e-01 | 0.010 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.771844e-01 | 0.010 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.780418e-01 | 0.010 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.780589e-01 | 0.010 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.788907e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.796613e-01 | 0.009 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.802981e-01 | 0.009 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.804257e-01 | 0.009 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.814849e-01 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.818530e-01 | 0.008 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.824057e-01 | 0.008 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.832073e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.841898e-01 | 0.007 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.844346e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.844463e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.850312e-01 | 0.007 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.855941e-01 | 0.006 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.866573e-01 | 0.006 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.866915e-01 | 0.006 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.871591e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.887296e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.901822e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.902389e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.905516e-01 | 0.004 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.912494e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.924586e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.924944e-01 | 0.003 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.940445e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.942627e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.944353e-01 | 0.002 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.945572e-01 | 0.002 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.946867e-01 | 0.002 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.950255e-01 | 0.002 | 0 | 0 |
| Translation | R-HSA-72766 | 9.954217e-01 | 0.002 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.957968e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.959392e-01 | 0.002 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.963812e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.968589e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.972347e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.973389e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.973950e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.977120e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.978871e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.983225e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.986706e-01 | 0.001 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.989331e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.991064e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.991610e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.992454e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.993079e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.994095e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.994685e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.995807e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.997036e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998216e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.998663e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999317e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999337e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999354e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999750e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999809e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999861e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999947e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Peptide chain elongation | R-HSA-156902 | 1.110223e-16 | 15.955 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.330669e-16 | 15.477 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.440892e-16 | 15.353 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.771561e-16 | 15.109 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.771561e-16 | 15.109 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.881784e-16 | 15.051 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.665335e-15 | 14.778 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.108624e-15 | 14.507 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.997602e-15 | 14.523 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.997602e-15 | 14.523 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.108624e-15 | 14.507 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.663736e-15 | 14.436 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.995204e-15 | 14.222 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.328271e-15 | 14.199 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.327472e-15 | 14.135 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.327472e-15 | 14.135 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.010303e-14 | 13.996 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.099121e-14 | 13.959 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.165734e-14 | 13.933 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.365574e-14 | 13.865 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.776357e-14 | 13.750 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.542411e-14 | 13.595 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.586020e-14 | 13.445 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.205347e-14 | 13.142 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.525714e-14 | 13.021 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.947598e-14 | 13.002 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.337819e-13 | 12.874 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.504352e-13 | 12.823 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.598721e-13 | 12.796 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.784128e-13 | 12.749 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.049472e-13 | 12.688 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.371747e-13 | 12.472 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.034550e-13 | 12.394 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.679590e-13 | 12.330 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.070699e-13 | 12.217 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.419310e-13 | 12.193 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.293055e-13 | 12.137 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.616130e-13 | 12.118 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.193757e-13 | 12.037 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.543477e-13 | 12.020 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.074918e-12 | 11.969 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.366462e-12 | 11.864 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.390221e-12 | 11.857 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.948997e-12 | 11.710 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.271117e-12 | 11.278 | 0 | 0 |
| Translation | R-HSA-72766 | 7.741585e-12 | 11.111 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.776779e-12 | 11.109 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.156031e-12 | 11.089 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.497092e-12 | 11.071 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.817835e-12 | 11.055 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.268441e-11 | 10.897 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.815281e-11 | 10.741 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.549294e-11 | 10.594 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.773914e-11 | 10.557 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.461309e-11 | 10.461 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.434508e-11 | 10.265 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.907341e-11 | 10.161 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.702827e-11 | 10.113 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.066281e-11 | 10.093 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.074282e-10 | 9.969 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.387264e-10 | 9.858 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.645204e-10 | 9.784 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.645177e-10 | 9.578 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.064272e-10 | 9.514 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.876133e-10 | 9.312 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.674844e-10 | 9.115 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.807939e-10 | 9.107 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.355043e-10 | 9.078 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.006616e-09 | 8.997 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.072063e-09 | 8.970 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.895647e-09 | 8.722 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.906612e-09 | 8.720 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.671739e-09 | 8.573 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.671739e-09 | 8.573 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.864541e-09 | 8.543 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.487094e-09 | 8.458 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.666551e-09 | 8.331 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.416006e-09 | 8.130 | 1 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.528702e-09 | 8.021 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.588859e-09 | 8.018 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.029240e-08 | 7.987 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.288494e-08 | 7.890 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.960677e-08 | 7.708 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.095747e-08 | 7.679 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.144881e-08 | 7.669 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.463788e-08 | 7.608 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.678404e-08 | 7.572 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.832838e-08 | 7.548 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.248896e-08 | 7.488 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.248896e-08 | 7.488 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.059444e-08 | 7.392 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.071539e-08 | 7.390 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.071539e-08 | 7.390 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.615745e-08 | 7.336 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.677907e-08 | 7.330 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.715510e-08 | 7.243 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.833723e-08 | 7.165 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.574681e-08 | 7.067 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.963871e-08 | 7.002 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.120359e-07 | 6.951 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.123565e-07 | 6.949 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.450550e-07 | 6.838 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.450550e-07 | 6.838 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.468047e-07 | 6.833 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.710368e-07 | 6.767 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.068024e-07 | 6.684 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.133287e-07 | 6.671 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.394372e-07 | 6.621 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.402605e-07 | 6.619 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.822271e-07 | 6.549 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.824020e-07 | 6.549 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.918498e-07 | 6.535 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.991889e-07 | 6.524 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.473569e-07 | 6.459 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.623511e-07 | 6.441 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.844682e-07 | 6.415 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.678104e-07 | 6.330 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.314425e-07 | 6.365 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.079901e-07 | 6.294 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.221245e-07 | 6.141 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.378187e-07 | 6.132 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.033706e-07 | 6.095 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.164497e-07 | 6.088 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.001863e-06 | 5.999 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.021184e-06 | 5.991 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.146177e-06 | 5.941 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.156771e-06 | 5.937 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.158151e-06 | 5.936 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.158151e-06 | 5.936 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.388800e-06 | 5.857 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.452963e-06 | 5.838 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.418910e-06 | 5.848 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.518733e-06 | 5.819 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.535312e-06 | 5.814 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.539490e-06 | 5.813 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.921630e-06 | 5.716 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.025416e-06 | 5.693 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.279698e-06 | 5.642 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.324079e-06 | 5.634 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.694051e-06 | 5.570 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.863776e-06 | 5.543 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.172987e-06 | 5.499 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.452694e-06 | 5.462 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.733019e-06 | 5.428 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.375029e-06 | 5.359 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.471525e-06 | 5.350 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.471525e-06 | 5.350 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.534303e-06 | 5.343 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.841700e-06 | 5.315 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.028123e-06 | 5.299 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.697830e-06 | 5.244 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.178820e-06 | 5.209 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.209334e-06 | 5.207 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.489446e-06 | 5.188 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.100637e-06 | 5.149 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.573416e-06 | 5.121 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.435658e-06 | 5.074 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.191055e-06 | 5.037 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.191055e-06 | 5.037 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.191055e-06 | 5.037 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.191055e-06 | 5.037 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.191055e-06 | 5.037 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.821357e-06 | 5.008 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.821357e-06 | 5.008 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.153943e-05 | 4.938 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.216023e-05 | 4.915 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.282272e-05 | 4.892 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.289861e-05 | 4.889 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.500108e-05 | 4.824 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.546023e-05 | 4.811 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.558839e-05 | 4.807 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.577454e-05 | 4.802 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.577454e-05 | 4.802 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.738017e-05 | 4.760 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.925049e-05 | 4.716 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.926171e-05 | 4.715 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.032279e-05 | 4.692 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.036805e-05 | 4.691 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.058870e-05 | 4.686 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.146266e-05 | 4.668 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.276342e-05 | 4.643 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.276342e-05 | 4.643 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.279082e-05 | 4.642 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.492471e-05 | 4.603 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.646117e-05 | 4.577 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.712435e-05 | 4.567 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.785915e-05 | 4.555 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.970135e-05 | 4.527 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.145360e-05 | 4.502 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.196259e-05 | 4.495 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.381191e-05 | 4.471 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.402099e-05 | 4.468 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.918773e-05 | 4.407 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.754354e-05 | 4.425 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.717076e-05 | 4.430 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.809470e-05 | 4.318 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.559136e-05 | 4.255 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.591296e-05 | 4.252 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.626360e-05 | 4.250 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.672053e-05 | 4.246 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.723269e-05 | 4.242 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.263275e-05 | 4.203 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.526374e-05 | 4.185 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.885855e-05 | 4.162 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.143212e-05 | 4.146 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.143212e-05 | 4.146 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.169410e-05 | 4.145 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.169410e-05 | 4.145 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.905253e-05 | 4.102 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.349840e-05 | 4.078 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.344677e-05 | 4.029 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.344677e-05 | 4.029 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.387501e-05 | 4.027 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.387501e-05 | 4.027 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.905260e-05 | 4.004 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.905260e-05 | 4.004 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.994150e-05 | 4.000 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.097870e-04 | 3.959 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.105865e-04 | 3.956 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.124048e-04 | 3.949 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.205690e-04 | 3.919 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.255855e-04 | 3.901 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.317310e-04 | 3.880 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.436639e-04 | 3.843 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.548355e-04 | 3.810 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.374233e-04 | 3.862 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.506803e-04 | 3.822 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.548355e-04 | 3.810 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.689922e-04 | 3.772 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.766158e-04 | 3.753 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.812447e-04 | 3.742 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.871521e-04 | 3.728 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.091375e-04 | 3.680 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.174825e-04 | 3.663 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.529413e-04 | 3.597 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.574737e-04 | 3.589 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.672793e-04 | 3.573 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.687824e-04 | 3.571 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.687824e-04 | 3.571 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.687824e-04 | 3.571 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.774007e-04 | 3.557 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.977715e-04 | 3.526 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.977715e-04 | 3.526 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.038403e-04 | 3.517 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.081036e-04 | 3.511 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.205328e-04 | 3.494 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.274197e-04 | 3.485 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.380325e-04 | 3.471 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.467441e-04 | 3.460 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.467441e-04 | 3.460 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.600956e-04 | 3.444 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.987329e-04 | 3.399 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.987329e-04 | 3.399 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.045516e-04 | 3.393 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.292546e-04 | 3.367 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.789424e-04 | 3.320 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.828680e-04 | 3.316 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.075139e-04 | 3.295 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.082014e-04 | 3.294 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.581209e-04 | 3.253 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.816429e-04 | 3.235 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.954609e-04 | 3.225 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.954609e-04 | 3.225 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.757614e-04 | 3.170 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.447773e-04 | 3.191 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.396671e-04 | 3.194 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.542838e-04 | 3.122 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.396671e-04 | 3.194 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.184571e-04 | 3.209 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.337363e-04 | 3.134 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.950969e-04 | 3.158 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.710511e-04 | 3.113 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.744565e-04 | 3.111 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.770483e-04 | 3.110 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.323141e-04 | 3.080 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.323141e-04 | 3.080 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.497255e-04 | 3.071 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.588007e-04 | 3.066 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.588007e-04 | 3.066 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.588007e-04 | 3.066 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.588007e-04 | 3.066 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.588007e-04 | 3.066 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.588007e-04 | 3.066 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.588007e-04 | 3.066 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.588007e-04 | 3.066 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.789915e-04 | 3.056 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.791026e-04 | 3.056 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 8.791026e-04 | 3.056 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.337775e-04 | 3.030 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.437767e-04 | 3.025 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.522803e-04 | 3.021 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.628358e-04 | 3.016 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.893724e-04 | 3.005 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.915218e-04 | 3.004 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.028712e-03 | 2.988 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.061319e-03 | 2.974 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.061319e-03 | 2.974 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.061319e-03 | 2.974 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.075115e-03 | 2.969 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.076417e-03 | 2.968 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.095520e-03 | 2.960 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.095520e-03 | 2.960 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.095520e-03 | 2.960 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.104238e-03 | 2.957 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.184791e-03 | 2.926 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.208843e-03 | 2.918 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.232724e-03 | 2.909 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.332437e-03 | 2.875 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.332437e-03 | 2.875 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.332437e-03 | 2.875 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.616633e-03 | 2.791 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.616633e-03 | 2.791 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.696414e-03 | 2.770 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.407866e-03 | 2.851 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.766816e-03 | 2.753 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.752433e-03 | 2.756 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.630782e-03 | 2.788 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.766816e-03 | 2.753 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.510780e-03 | 2.821 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.445682e-03 | 2.840 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.868334e-03 | 2.729 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.601847e-03 | 2.795 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.816012e-03 | 2.741 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.510780e-03 | 2.821 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.616633e-03 | 2.791 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.957264e-03 | 2.708 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.975456e-03 | 2.704 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.062379e-03 | 2.686 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.111349e-03 | 2.675 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.111349e-03 | 2.675 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.195937e-03 | 2.658 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.232281e-03 | 2.651 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.238040e-03 | 2.650 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.284409e-03 | 2.641 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.310470e-03 | 2.636 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.362538e-03 | 2.627 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.362538e-03 | 2.627 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.370517e-03 | 2.625 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.400362e-03 | 2.620 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.519514e-03 | 2.599 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.524768e-03 | 2.598 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.593637e-03 | 2.586 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.593637e-03 | 2.586 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.593637e-03 | 2.586 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.593637e-03 | 2.586 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.698916e-03 | 2.569 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.701718e-03 | 2.568 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.701718e-03 | 2.568 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.701718e-03 | 2.568 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.902735e-03 | 2.537 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.902735e-03 | 2.537 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.902735e-03 | 2.537 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.012003e-03 | 2.521 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.030947e-03 | 2.518 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.084933e-03 | 2.511 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.098037e-03 | 2.509 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.098037e-03 | 2.509 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.098037e-03 | 2.509 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.116969e-03 | 2.506 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.120393e-03 | 2.506 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.239277e-03 | 2.490 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.239277e-03 | 2.490 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.252908e-03 | 2.488 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.328214e-03 | 2.478 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.366083e-03 | 2.473 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.396247e-03 | 2.469 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.396247e-03 | 2.469 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.396247e-03 | 2.469 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.396247e-03 | 2.469 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.532108e-03 | 2.452 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.604804e-03 | 2.443 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.654306e-03 | 2.437 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.690127e-03 | 2.433 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.763083e-03 | 2.424 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.828541e-03 | 2.417 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.899083e-03 | 2.409 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.937318e-03 | 2.405 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.000877e-03 | 2.398 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.000877e-03 | 2.398 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.203168e-03 | 2.376 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.203168e-03 | 2.376 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.923502e-03 | 2.227 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.504810e-03 | 2.346 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.064329e-03 | 2.295 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.481032e-03 | 2.349 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.333844e-03 | 2.198 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.185453e-03 | 2.209 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.130389e-03 | 2.290 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.185453e-03 | 2.209 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.261565e-03 | 2.279 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.261565e-03 | 2.279 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.673196e-03 | 2.246 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.673196e-03 | 2.246 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.130389e-03 | 2.290 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.495335e-03 | 2.187 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.337804e-03 | 2.198 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.130389e-03 | 2.290 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.686997e-03 | 2.245 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.504810e-03 | 2.346 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.064329e-03 | 2.295 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.064329e-03 | 2.295 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.333844e-03 | 2.198 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.333844e-03 | 2.198 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.891010e-03 | 2.311 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.536766e-03 | 2.343 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.388279e-03 | 2.269 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.235836e-03 | 2.205 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.185453e-03 | 2.209 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.185453e-03 | 2.209 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.495335e-03 | 2.187 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.495335e-03 | 2.187 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.245327e-03 | 2.280 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.333844e-03 | 2.198 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.059706e-03 | 2.296 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.130389e-03 | 2.290 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.481032e-03 | 2.349 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.333844e-03 | 2.198 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.999739e-03 | 2.222 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.337154e-03 | 2.273 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.565128e-03 | 2.183 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.722210e-03 | 2.172 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.942012e-03 | 2.159 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.967086e-03 | 2.157 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.967086e-03 | 2.157 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.048692e-03 | 2.152 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.048692e-03 | 2.152 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.048692e-03 | 2.152 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.048692e-03 | 2.152 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.108382e-03 | 2.148 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.265112e-03 | 2.139 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.375502e-03 | 2.132 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.375502e-03 | 2.132 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.385085e-03 | 2.132 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.763288e-03 | 2.110 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.763288e-03 | 2.110 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.763288e-03 | 2.110 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.836000e-03 | 2.106 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.461683e-03 | 2.073 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.461683e-03 | 2.073 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.461683e-03 | 2.073 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.650584e-03 | 2.063 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.650584e-03 | 2.063 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.650584e-03 | 2.063 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.703927e-03 | 2.060 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.703927e-03 | 2.060 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.703927e-03 | 2.060 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.707251e-03 | 2.060 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.707251e-03 | 2.060 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.707251e-03 | 2.060 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.707251e-03 | 2.060 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.867397e-03 | 2.052 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.867397e-03 | 2.052 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.906691e-03 | 2.050 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.205193e-03 | 2.036 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.542360e-03 | 2.020 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.988888e-03 | 2.000 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.988888e-03 | 2.000 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.995433e-03 | 2.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.995433e-03 | 2.000 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.018697e-02 | 1.992 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.018697e-02 | 1.992 | 1 | 1 |
| Glycogen storage diseases | R-HSA-3229121 | 1.018697e-02 | 1.992 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.027299e-02 | 1.988 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.027299e-02 | 1.988 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.027299e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.027299e-02 | 1.988 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.039357e-02 | 1.983 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.046782e-02 | 1.980 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.046782e-02 | 1.980 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.049779e-02 | 1.979 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.049779e-02 | 1.979 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.049779e-02 | 1.979 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.068232e-02 | 1.971 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.083401e-02 | 1.965 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.099335e-02 | 1.959 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.099335e-02 | 1.959 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.120400e-02 | 1.951 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.120400e-02 | 1.951 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.122738e-02 | 1.950 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.122738e-02 | 1.950 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.122738e-02 | 1.950 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.151915e-02 | 1.939 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.151915e-02 | 1.939 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.151915e-02 | 1.939 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.172250e-02 | 1.931 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.182044e-02 | 1.927 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.251613e-02 | 1.903 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.260867e-02 | 1.899 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.260867e-02 | 1.899 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.325004e-02 | 1.878 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.325004e-02 | 1.878 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.329635e-02 | 1.876 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.359845e-02 | 1.867 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.361300e-02 | 1.866 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.392853e-02 | 1.856 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.392853e-02 | 1.856 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.396396e-02 | 1.855 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.521735e-02 | 1.818 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.548402e-02 | 1.810 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.556947e-02 | 1.808 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.556947e-02 | 1.808 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.566000e-02 | 1.805 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.568771e-02 | 1.804 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.630764e-02 | 1.788 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.630764e-02 | 1.788 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.630764e-02 | 1.788 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.630764e-02 | 1.788 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.630764e-02 | 1.788 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.706638e-02 | 1.768 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.706638e-02 | 1.768 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.706638e-02 | 1.768 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.725621e-02 | 1.763 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.769096e-02 | 1.752 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.769096e-02 | 1.752 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.769417e-02 | 1.752 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.769417e-02 | 1.752 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.769417e-02 | 1.752 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.769417e-02 | 1.752 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.772658e-02 | 1.751 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.879754e-02 | 1.726 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.897525e-02 | 1.722 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.915270e-02 | 1.718 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.934311e-02 | 1.713 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.946867e-02 | 1.711 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.949561e-02 | 1.710 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.999096e-02 | 1.699 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.999096e-02 | 1.699 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.999096e-02 | 1.699 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.999096e-02 | 1.699 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.999096e-02 | 1.699 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.023362e-02 | 1.694 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.064040e-02 | 1.685 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.064040e-02 | 1.685 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.064040e-02 | 1.685 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.064040e-02 | 1.685 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.069471e-02 | 1.684 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.200207e-02 | 1.658 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.200207e-02 | 1.658 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.200207e-02 | 1.658 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.221624e-02 | 1.653 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.231875e-02 | 1.651 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.246317e-02 | 1.649 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.246317e-02 | 1.649 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.246317e-02 | 1.649 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.313391e-02 | 1.636 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.313391e-02 | 1.636 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.335528e-02 | 1.632 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.335528e-02 | 1.632 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.390315e-02 | 1.622 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.434391e-02 | 1.614 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.467068e-02 | 1.608 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.522108e-02 | 1.598 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.922141e-02 | 1.534 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.922141e-02 | 1.534 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.724464e-02 | 1.429 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.600260e-02 | 1.337 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.600260e-02 | 1.337 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.092125e-02 | 1.388 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.610926e-02 | 1.336 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.160539e-02 | 1.287 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.160539e-02 | 1.287 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.160539e-02 | 1.287 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.095848e-02 | 1.509 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.095848e-02 | 1.509 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.753877e-02 | 1.426 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.769946e-02 | 1.558 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.769946e-02 | 1.558 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.259009e-02 | 1.371 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.611415e-02 | 1.442 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.087476e-02 | 1.389 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.587229e-02 | 1.445 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.999516e-02 | 1.398 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.808041e-02 | 1.419 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.415615e-02 | 1.467 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.230875e-02 | 1.374 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.230875e-02 | 1.374 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.230875e-02 | 1.374 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.392048e-02 | 1.470 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.600260e-02 | 1.337 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.002459e-02 | 1.398 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.486062e-02 | 1.348 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.966758e-02 | 1.528 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.387375e-02 | 1.470 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.092125e-02 | 1.388 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.587229e-02 | 1.445 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.922141e-02 | 1.534 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.095848e-02 | 1.509 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.726107e-02 | 1.564 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.794480e-02 | 1.554 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.110689e-02 | 1.386 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.872763e-02 | 1.312 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.966758e-02 | 1.528 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.160831e-02 | 1.500 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.969347e-02 | 1.304 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.149267e-02 | 1.502 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.092125e-02 | 1.388 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.689774e-02 | 1.570 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.115483e-02 | 1.506 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.436588e-02 | 1.353 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.917438e-02 | 1.535 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.436588e-02 | 1.353 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.568194e-02 | 1.448 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.673890e-02 | 1.330 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.737785e-02 | 1.324 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.686239e-02 | 1.571 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.872763e-02 | 1.312 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.563916e-02 | 1.448 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.872763e-02 | 1.312 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.073826e-02 | 1.390 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.415615e-02 | 1.467 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.753877e-02 | 1.426 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.824307e-02 | 1.549 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.753877e-02 | 1.426 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.711518e-02 | 1.430 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.682305e-02 | 1.571 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.677738e-02 | 1.434 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.686239e-02 | 1.571 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.160831e-02 | 1.500 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.387375e-02 | 1.470 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.204061e-02 | 1.494 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.923329e-02 | 1.308 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.611415e-02 | 1.442 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.565203e-02 | 1.341 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.884190e-02 | 1.311 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.884190e-02 | 1.311 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.160831e-02 | 1.500 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.996069e-02 | 1.398 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.879967e-02 | 1.312 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.441549e-02 | 1.352 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.167237e-02 | 1.287 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.216001e-02 | 1.283 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.216001e-02 | 1.283 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.225502e-02 | 1.282 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.254102e-02 | 1.280 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.323956e-02 | 1.274 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.543016e-02 | 1.256 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.543016e-02 | 1.256 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.543016e-02 | 1.256 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.543016e-02 | 1.256 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.543016e-02 | 1.256 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.543016e-02 | 1.256 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.560651e-02 | 1.255 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.560651e-02 | 1.255 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.582074e-02 | 1.253 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.652320e-02 | 1.248 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.680025e-02 | 1.246 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.711001e-02 | 1.243 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.723056e-02 | 1.242 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.723056e-02 | 1.242 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.724113e-02 | 1.242 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.724113e-02 | 1.242 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.724113e-02 | 1.242 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.740277e-02 | 1.241 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.740277e-02 | 1.241 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.740277e-02 | 1.241 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.744926e-02 | 1.241 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.918137e-02 | 1.228 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.933501e-02 | 1.227 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.988680e-02 | 1.223 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.033860e-02 | 1.219 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.171991e-02 | 1.210 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.171991e-02 | 1.210 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.171991e-02 | 1.210 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.171991e-02 | 1.210 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.283458e-02 | 1.202 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.288435e-02 | 1.201 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.349377e-02 | 1.197 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.349377e-02 | 1.197 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.546595e-02 | 1.184 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.546595e-02 | 1.184 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.546595e-02 | 1.184 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.546595e-02 | 1.184 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.546595e-02 | 1.184 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.546595e-02 | 1.184 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.546595e-02 | 1.184 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.559205e-02 | 1.183 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.671507e-02 | 1.176 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.704828e-02 | 1.174 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.810769e-02 | 1.167 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.810769e-02 | 1.167 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.815820e-02 | 1.166 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.815820e-02 | 1.166 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.987009e-02 | 1.156 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.044324e-02 | 1.152 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.113085e-02 | 1.148 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.123758e-02 | 1.147 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.123758e-02 | 1.147 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.123758e-02 | 1.147 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.123758e-02 | 1.147 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.123758e-02 | 1.147 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.127678e-02 | 1.147 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.262231e-02 | 1.139 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 7.262231e-02 | 1.139 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 7.262231e-02 | 1.139 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.262231e-02 | 1.139 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.262231e-02 | 1.139 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.262231e-02 | 1.139 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.289993e-02 | 1.137 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.349528e-02 | 1.134 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.393561e-02 | 1.131 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.580937e-02 | 1.120 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.580937e-02 | 1.120 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.605223e-02 | 1.119 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.605223e-02 | 1.119 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.605223e-02 | 1.119 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.605223e-02 | 1.119 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.605223e-02 | 1.119 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.605223e-02 | 1.119 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.626139e-02 | 1.118 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.626139e-02 | 1.118 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.626139e-02 | 1.118 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.652288e-02 | 1.116 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.652288e-02 | 1.116 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.752511e-02 | 1.111 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.344275e-02 | 1.079 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.400892e-02 | 1.076 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.505036e-02 | 1.070 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.713469e-02 | 1.060 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.713469e-02 | 1.060 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.713469e-02 | 1.060 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.775155e-02 | 1.057 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.887218e-02 | 1.051 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.887218e-02 | 1.051 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.061995e-02 | 1.043 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.091842e-02 | 1.041 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.415047e-02 | 1.026 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.448716e-02 | 1.025 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.448716e-02 | 1.025 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.691317e-02 | 1.014 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.703884e-02 | 1.013 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.703884e-02 | 1.013 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.703884e-02 | 1.013 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.703884e-02 | 1.013 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.703884e-02 | 1.013 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.805724e-02 | 1.009 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.866227e-02 | 1.006 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.039147e-01 | 0.983 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.039147e-01 | 0.983 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.039147e-01 | 0.983 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.039147e-01 | 0.983 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.039147e-01 | 0.983 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.039147e-01 | 0.983 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.042352e-01 | 0.982 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.045338e-01 | 0.981 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.057056e-01 | 0.976 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.057056e-01 | 0.976 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.057056e-01 | 0.976 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.069342e-01 | 0.971 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.069342e-01 | 0.971 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.074223e-01 | 0.969 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.096734e-01 | 0.960 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.099281e-01 | 0.959 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.105870e-01 | 0.956 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.105870e-01 | 0.956 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.105870e-01 | 0.956 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 1.118448e-01 | 0.951 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 1.135929e-01 | 0.945 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 1.135929e-01 | 0.945 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 1.135929e-01 | 0.945 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.135929e-01 | 0.945 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.141093e-01 | 0.943 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.148957e-01 | 0.940 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.170091e-01 | 0.932 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.216030e-01 | 0.915 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.216957e-01 | 0.915 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.222845e-01 | 0.913 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 1.224063e-01 | 0.912 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 1.224063e-01 | 0.912 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.224063e-01 | 0.912 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.228638e-01 | 0.911 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.228638e-01 | 0.911 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.228638e-01 | 0.911 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.228638e-01 | 0.911 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.228638e-01 | 0.911 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.228638e-01 | 0.911 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.257724e-01 | 0.900 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.300030e-01 | 0.886 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.300030e-01 | 0.886 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.300030e-01 | 0.886 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.300134e-01 | 0.886 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.327338e-01 | 0.877 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.354505e-01 | 0.868 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.354505e-01 | 0.868 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.383539e-01 | 0.859 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.385037e-01 | 0.859 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.385037e-01 | 0.859 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.387067e-01 | 0.858 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.399787e-01 | 0.854 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.399787e-01 | 0.854 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.399787e-01 | 0.854 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.419386e-01 | 0.848 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.421864e-01 | 0.847 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.421864e-01 | 0.847 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.421864e-01 | 0.847 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.483074e-01 | 0.829 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.483074e-01 | 0.829 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 1.490447e-01 | 0.827 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.522597e-01 | 0.817 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.613973e-01 | 0.792 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.631297e-01 | 0.787 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.664022e-01 | 0.779 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.703465e-01 | 0.769 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.718024e-01 | 0.765 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.718024e-01 | 0.765 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.718024e-01 | 0.765 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.718024e-01 | 0.765 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.739125e-01 | 0.760 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.742219e-01 | 0.759 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.743659e-01 | 0.759 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.746856e-01 | 0.758 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.746856e-01 | 0.758 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.794289e-01 | 0.746 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 1.851034e-01 | 0.733 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.879493e-01 | 0.726 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.881397e-01 | 0.726 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.881397e-01 | 0.726 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.881397e-01 | 0.726 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 1.881397e-01 | 0.726 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.881397e-01 | 0.726 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.929577e-01 | 0.715 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.002572e-01 | 0.698 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.019980e-01 | 0.695 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.024503e-01 | 0.694 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.024503e-01 | 0.694 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.024503e-01 | 0.694 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.024503e-01 | 0.694 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.024503e-01 | 0.694 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.025075e-01 | 0.694 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.055047e-01 | 0.687 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.064068e-01 | 0.685 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.067441e-01 | 0.685 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.121646e-01 | 0.673 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.121646e-01 | 0.673 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.148155e-01 | 0.668 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.154259e-01 | 0.667 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.154259e-01 | 0.667 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.154259e-01 | 0.667 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.154259e-01 | 0.667 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.154259e-01 | 0.667 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.154259e-01 | 0.667 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 2.154259e-01 | 0.667 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.219189e-01 | 0.654 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.219189e-01 | 0.654 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.219189e-01 | 0.654 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.264959e-01 | 0.645 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 2.292030e-01 | 0.640 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.292030e-01 | 0.640 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.292030e-01 | 0.640 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.292030e-01 | 0.640 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.316005e-01 | 0.635 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.319660e-01 | 0.635 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.319660e-01 | 0.635 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.319660e-01 | 0.635 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.319660e-01 | 0.635 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.319660e-01 | 0.635 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.319660e-01 | 0.635 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.330235e-01 | 0.633 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.391786e-01 | 0.621 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.401969e-01 | 0.619 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.416795e-01 | 0.617 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.430361e-01 | 0.614 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.430361e-01 | 0.614 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.430361e-01 | 0.614 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.430361e-01 | 0.614 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.441000e-01 | 0.612 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.441000e-01 | 0.612 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.441000e-01 | 0.612 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.501812e-01 | 0.602 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.501812e-01 | 0.602 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.516666e-01 | 0.599 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.516666e-01 | 0.599 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.516666e-01 | 0.599 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.516666e-01 | 0.599 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 2.558253e-01 | 0.592 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.558253e-01 | 0.592 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.558253e-01 | 0.592 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.558253e-01 | 0.592 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.558253e-01 | 0.592 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.558253e-01 | 0.592 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.569022e-01 | 0.590 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.569022e-01 | 0.590 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.569022e-01 | 0.590 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.569022e-01 | 0.590 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.603910e-01 | 0.584 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.603910e-01 | 0.584 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.603910e-01 | 0.584 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.603910e-01 | 0.584 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.603910e-01 | 0.584 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.603910e-01 | 0.584 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.603910e-01 | 0.584 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.603910e-01 | 0.584 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.603910e-01 | 0.584 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.603910e-01 | 0.584 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.603910e-01 | 0.584 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.603910e-01 | 0.584 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 2.603910e-01 | 0.584 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.603910e-01 | 0.584 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.617125e-01 | 0.582 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.617125e-01 | 0.582 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.617125e-01 | 0.582 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.628768e-01 | 0.580 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.640167e-01 | 0.578 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.707800e-01 | 0.567 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.707800e-01 | 0.567 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.707800e-01 | 0.567 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.722564e-01 | 0.565 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.722564e-01 | 0.565 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.825031e-01 | 0.549 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.877657e-01 | 0.541 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.877657e-01 | 0.541 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.877657e-01 | 0.541 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.877657e-01 | 0.541 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.877657e-01 | 0.541 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.877657e-01 | 0.541 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.877657e-01 | 0.541 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.888610e-01 | 0.539 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.921135e-01 | 0.534 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.984926e-01 | 0.525 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.984926e-01 | 0.525 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.984926e-01 | 0.525 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.007620e-01 | 0.522 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.023067e-01 | 0.520 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.023067e-01 | 0.520 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.096841e-01 | 0.509 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.122921e-01 | 0.505 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.122921e-01 | 0.505 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.122921e-01 | 0.505 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.122921e-01 | 0.505 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.125161e-01 | 0.505 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.141288e-01 | 0.503 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.141288e-01 | 0.503 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.141288e-01 | 0.503 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.141288e-01 | 0.503 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.141288e-01 | 0.503 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.201061e-01 | 0.495 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.227341e-01 | 0.491 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.227341e-01 | 0.491 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.260324e-01 | 0.487 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.260324e-01 | 0.487 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.260324e-01 | 0.487 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.260324e-01 | 0.487 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.329531e-01 | 0.478 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.395177e-01 | 0.469 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.395177e-01 | 0.469 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.395177e-01 | 0.469 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.395177e-01 | 0.469 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.395177e-01 | 0.469 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.395177e-01 | 0.469 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.396990e-01 | 0.469 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.522689e-01 | 0.453 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.532786e-01 | 0.452 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.532786e-01 | 0.452 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 3.555381e-01 | 0.449 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.561999e-01 | 0.448 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.562685e-01 | 0.448 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.639682e-01 | 0.439 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.639682e-01 | 0.439 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.639682e-01 | 0.439 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.639682e-01 | 0.439 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.639682e-01 | 0.439 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.639682e-01 | 0.439 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.639682e-01 | 0.439 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.647333e-01 | 0.438 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.667588e-01 | 0.436 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.667588e-01 | 0.436 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.667588e-01 | 0.436 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.667588e-01 | 0.436 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.731205e-01 | 0.428 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.776989e-01 | 0.423 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.801286e-01 | 0.420 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.801286e-01 | 0.420 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.801286e-01 | 0.420 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.801286e-01 | 0.420 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.875150e-01 | 0.412 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.875150e-01 | 0.412 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.875150e-01 | 0.412 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.875150e-01 | 0.412 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.875150e-01 | 0.412 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.875150e-01 | 0.412 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.875150e-01 | 0.412 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.875150e-01 | 0.412 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.900821e-01 | 0.409 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.933775e-01 | 0.405 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.933775e-01 | 0.405 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.933775e-01 | 0.405 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.939076e-01 | 0.405 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.939076e-01 | 0.405 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.939076e-01 | 0.405 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.039487e-01 | 0.394 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.064962e-01 | 0.391 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.064962e-01 | 0.391 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.064962e-01 | 0.391 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.064962e-01 | 0.391 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.101915e-01 | 0.387 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.101915e-01 | 0.387 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.101915e-01 | 0.387 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.101915e-01 | 0.387 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.101915e-01 | 0.387 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.101915e-01 | 0.387 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.101915e-01 | 0.387 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.101915e-01 | 0.387 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.101915e-01 | 0.387 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.108938e-01 | 0.386 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.145633e-01 | 0.382 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.194763e-01 | 0.377 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.320297e-01 | 0.364 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.320297e-01 | 0.364 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.320297e-01 | 0.364 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.320297e-01 | 0.364 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.320297e-01 | 0.364 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.320297e-01 | 0.364 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.323100e-01 | 0.364 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.323100e-01 | 0.364 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.323100e-01 | 0.364 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.323100e-01 | 0.364 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.323100e-01 | 0.364 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.323100e-01 | 0.364 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.449905e-01 | 0.352 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.449905e-01 | 0.352 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.449905e-01 | 0.352 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.530606e-01 | 0.344 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.530606e-01 | 0.344 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.530606e-01 | 0.344 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.530606e-01 | 0.344 | 0 | 0 |
| Acetylation | R-HSA-156582 | 4.530606e-01 | 0.344 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.530606e-01 | 0.344 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.530606e-01 | 0.344 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.530606e-01 | 0.344 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 4.575113e-01 | 0.340 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.575113e-01 | 0.340 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.575113e-01 | 0.340 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.575113e-01 | 0.340 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.590673e-01 | 0.338 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.630045e-01 | 0.334 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.630045e-01 | 0.334 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.630045e-01 | 0.334 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.630045e-01 | 0.334 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.698671e-01 | 0.328 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.726073e-01 | 0.325 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.733140e-01 | 0.325 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.733140e-01 | 0.325 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.733140e-01 | 0.325 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.733140e-01 | 0.325 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.733140e-01 | 0.325 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.733140e-01 | 0.325 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.733140e-01 | 0.325 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.733140e-01 | 0.325 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.733140e-01 | 0.325 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.820529e-01 | 0.317 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.820529e-01 | 0.317 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.820529e-01 | 0.317 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.821312e-01 | 0.317 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.821312e-01 | 0.317 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.928186e-01 | 0.307 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.928186e-01 | 0.307 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.928186e-01 | 0.307 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.928186e-01 | 0.307 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.928186e-01 | 0.307 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.928186e-01 | 0.307 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.928186e-01 | 0.307 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.940643e-01 | 0.306 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.940643e-01 | 0.306 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.052696e-01 | 0.296 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.058975e-01 | 0.296 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.058975e-01 | 0.296 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.058975e-01 | 0.296 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.058975e-01 | 0.296 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.116021e-01 | 0.291 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.116021e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.116021e-01 | 0.291 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.116021e-01 | 0.291 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.116021e-01 | 0.291 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.116021e-01 | 0.291 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.116021e-01 | 0.291 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.116021e-01 | 0.291 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.175493e-01 | 0.286 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.175493e-01 | 0.286 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.290169e-01 | 0.277 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.290169e-01 | 0.277 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.290169e-01 | 0.277 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.290169e-01 | 0.277 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.290169e-01 | 0.277 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.296910e-01 | 0.276 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.296910e-01 | 0.276 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.296910e-01 | 0.276 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.296910e-01 | 0.276 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 5.296910e-01 | 0.276 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.296910e-01 | 0.276 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.296910e-01 | 0.276 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.296910e-01 | 0.276 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.296910e-01 | 0.276 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.296910e-01 | 0.276 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.402979e-01 | 0.267 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.463285e-01 | 0.263 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.463285e-01 | 0.263 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.471110e-01 | 0.262 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.471110e-01 | 0.262 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.471110e-01 | 0.262 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.471110e-01 | 0.262 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.471110e-01 | 0.262 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.492461e-01 | 0.260 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.513905e-01 | 0.259 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.513905e-01 | 0.259 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.513928e-01 | 0.259 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 5.564897e-01 | 0.255 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.622931e-01 | 0.250 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.638868e-01 | 0.249 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.638868e-01 | 0.249 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.723814e-01 | 0.242 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.800422e-01 | 0.237 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.800422e-01 | 0.237 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.800422e-01 | 0.237 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.800422e-01 | 0.237 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.800422e-01 | 0.237 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.800422e-01 | 0.237 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.835241e-01 | 0.234 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.835241e-01 | 0.234 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.950585e-01 | 0.225 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.953411e-01 | 0.225 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.956001e-01 | 0.225 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.956001e-01 | 0.225 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.956001e-01 | 0.225 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.956001e-01 | 0.225 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.956001e-01 | 0.225 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.956001e-01 | 0.225 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.956001e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.974854e-01 | 0.224 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.039857e-01 | 0.219 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.039857e-01 | 0.219 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.039857e-01 | 0.219 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.105825e-01 | 0.214 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.105825e-01 | 0.214 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.105825e-01 | 0.214 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.105825e-01 | 0.214 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.105825e-01 | 0.214 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.105825e-01 | 0.214 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.185726e-01 | 0.209 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.236777e-01 | 0.205 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.250107e-01 | 0.204 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.250107e-01 | 0.204 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.250107e-01 | 0.204 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.389052e-01 | 0.195 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.389052e-01 | 0.195 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.426036e-01 | 0.192 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.497674e-01 | 0.187 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.499457e-01 | 0.187 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.522857e-01 | 0.186 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.522857e-01 | 0.186 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.522857e-01 | 0.186 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.522857e-01 | 0.186 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.522857e-01 | 0.186 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.522857e-01 | 0.186 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.522857e-01 | 0.186 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.522857e-01 | 0.186 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.607707e-01 | 0.180 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.651712e-01 | 0.177 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.651712e-01 | 0.177 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.651712e-01 | 0.177 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.651712e-01 | 0.177 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.651712e-01 | 0.177 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.651712e-01 | 0.177 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.651712e-01 | 0.177 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.775799e-01 | 0.169 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.775799e-01 | 0.169 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.775799e-01 | 0.169 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.775799e-01 | 0.169 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.775799e-01 | 0.169 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.775799e-01 | 0.169 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.809955e-01 | 0.167 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 6.866216e-01 | 0.163 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.895295e-01 | 0.161 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.895295e-01 | 0.161 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.947117e-01 | 0.158 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.948718e-01 | 0.158 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.010369e-01 | 0.154 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.010369e-01 | 0.154 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.010369e-01 | 0.154 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.010369e-01 | 0.154 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.010369e-01 | 0.154 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.010369e-01 | 0.154 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.029417e-01 | 0.153 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.082035e-01 | 0.150 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.108334e-01 | 0.148 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.121184e-01 | 0.147 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.121184e-01 | 0.147 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.121184e-01 | 0.147 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.185489e-01 | 0.144 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.185489e-01 | 0.144 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 7.207977e-01 | 0.142 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.210665e-01 | 0.142 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.227899e-01 | 0.141 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.227899e-01 | 0.141 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.227899e-01 | 0.141 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.227899e-01 | 0.141 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.260905e-01 | 0.139 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.260905e-01 | 0.139 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.301771e-01 | 0.137 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.301771e-01 | 0.137 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.327013e-01 | 0.135 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.330664e-01 | 0.135 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.330664e-01 | 0.135 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.330664e-01 | 0.135 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.330664e-01 | 0.135 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.406612e-01 | 0.130 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.429625e-01 | 0.129 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.429625e-01 | 0.129 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.429625e-01 | 0.129 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.429625e-01 | 0.129 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.429625e-01 | 0.129 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.429625e-01 | 0.129 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.429625e-01 | 0.129 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.451174e-01 | 0.128 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.539416e-01 | 0.123 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.541487e-01 | 0.123 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 7.545643e-01 | 0.122 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.584742e-01 | 0.120 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.584831e-01 | 0.120 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.616694e-01 | 0.118 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.705068e-01 | 0.113 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.705068e-01 | 0.113 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.745457e-01 | 0.111 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 7.790170e-01 | 0.108 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.790170e-01 | 0.108 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.872121e-01 | 0.104 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.872121e-01 | 0.104 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.872121e-01 | 0.104 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.951037e-01 | 0.100 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.956717e-01 | 0.099 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.027032e-01 | 0.095 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.027032e-01 | 0.095 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.028704e-01 | 0.095 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.039091e-01 | 0.095 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 8.094154e-01 | 0.092 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.100212e-01 | 0.092 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.170683e-01 | 0.088 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.170683e-01 | 0.088 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.191057e-01 | 0.087 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.200162e-01 | 0.086 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.238543e-01 | 0.084 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.238543e-01 | 0.084 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.238543e-01 | 0.084 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.303890e-01 | 0.081 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.303890e-01 | 0.081 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.303890e-01 | 0.081 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 8.366817e-01 | 0.077 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.366817e-01 | 0.077 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.366817e-01 | 0.077 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.396422e-01 | 0.076 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.427413e-01 | 0.074 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.427413e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.427413e-01 | 0.074 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.427413e-01 | 0.074 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.461366e-01 | 0.073 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.485764e-01 | 0.071 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.487144e-01 | 0.071 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 8.487144e-01 | 0.071 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.510036e-01 | 0.070 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.541953e-01 | 0.068 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.596061e-01 | 0.066 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.596061e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.648164e-01 | 0.063 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.648164e-01 | 0.063 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.686665e-01 | 0.061 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.710766e-01 | 0.060 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.746650e-01 | 0.058 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.793172e-01 | 0.056 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.793172e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.793172e-01 | 0.056 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.874252e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.881109e-01 | 0.052 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.001166e-01 | 0.046 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.056042e-01 | 0.043 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.108359e-01 | 0.041 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.115552e-01 | 0.040 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.180546e-01 | 0.037 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.204065e-01 | 0.036 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.233631e-01 | 0.035 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.262100e-01 | 0.033 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.278651e-01 | 0.033 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.289514e-01 | 0.032 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.289514e-01 | 0.032 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.315910e-01 | 0.031 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.341328e-01 | 0.030 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.389369e-01 | 0.027 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.412061e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.412061e-01 | 0.026 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.453221e-01 | 0.024 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.475210e-01 | 0.023 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.476579e-01 | 0.023 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.492184e-01 | 0.023 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.493991e-01 | 0.023 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.494717e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.549000e-01 | 0.020 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.552624e-01 | 0.020 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.552624e-01 | 0.020 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.565769e-01 | 0.019 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.612430e-01 | 0.017 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.626843e-01 | 0.017 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.626843e-01 | 0.017 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.644268e-01 | 0.016 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.694395e-01 | 0.013 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.724462e-01 | 0.012 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.724462e-01 | 0.012 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.755108e-01 | 0.011 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.755943e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.759623e-01 | 0.011 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.791015e-01 | 0.009 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.796574e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.825219e-01 | 0.008 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.834782e-01 | 0.007 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.839986e-01 | 0.007 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.844397e-01 | 0.007 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.872801e-01 | 0.006 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.927566e-01 | 0.003 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.944073e-01 | 0.002 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.961765e-01 | 0.002 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.979947e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.983861e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.985791e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.986834e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.990732e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.994194e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.995715e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.997552e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997636e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997932e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999911e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
